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Spinal cord injury (SCI) is extremely debilitating to patients and costly to 
our healthcare system. Since it is an important contributor to mortality and 
morbidity, various therapeutic strategies have been investigated, either 
experimentally or clinically, to improve patients’ quality of life. Studies utilizing 
pharmacological methods to mitigate the inhibitory components of the glial scar 
and facilitate axonal regeneration have been the primary experimental 
approaches in the field. However, the results are still not satisfactory. In this 
research, we aimed to tackle the issue from a novel perspective by developing 
cell derived, tissue engineered biomaterials that can be used in combination with 
other therapeutic approaches to improve the efficacy of current treatments.  
In this dissertation, a simple method to create either cellularized or 
acellular ECM biomaterial constructs is described. In particular, by utilizing 
patterned surface ligands, organized orientation can be introduced to the entire 
astrocyte derived construct morphologically and with regard to its associated 
matrix proteins, which mimics the native astrocyte framework within the spinal 
cord fiber tracts and provides these constructs the ability to guide axonal 
regeneration in vitro. In addition, meningeal fibroblast based biomaterial 
constructs are also developed taking advantage of the same engineering 
approach. It has been demonstrated that repairing damaged dura mater with 
iv 
 
allografts also benefits the regeneration process of the damaged spinal cord. In 
particular, acellular meningeal ECM constructs preserve a similar matrix protein 
profile as the native rat dura mater and support allogeneic meningeal cell 
adhesion and promote proliferation. 
The results suggest these engineered biomaterial constructs derived 
particularly from cells residing within tissue targeted for repair may carry 
appropriate tissue specific biological cues and hold therapeutic potentials for 
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1.1 General Spinal Cord Injury Facts 
 
The spinal cord is a long, tubular bundle of nervous tissue and cells that 
locates inside the vertebral canal and it is the main information pathway 
connecting the brain and peripheral nervous system (PNS). The spinal cord is 
divided into cervical, thoracic, lumbar and sacral segments (Fig. 1-1:A). Each 
segment has nerve fibers entering and exiting the spinal cord that are 
subsequently connecting to different parts of the body. The spinal cord is 
arranged with white matter on the outside and a butterfly shaped gray matter in 
the center. The gray matter is subdivided into dorsal horns and ventral horns, 
which contain groups of sensory or motor neurons that send out axons 
connecting to different parts of the body, respectively (Fig. 1-1:B and C). The 
white matter surrounding the gray matter is divided into dorsal, ventral and lateral 
columns. Each of these columns includes a variety of nerve fiber tracts that 
contain ascending sensory or descending motor nerve fibers. 
Spinal cord Injury (SCI) refers to any injury to the spinal column. Currently,  
there are nearly 200,000-250,000 people in the United States alone who suffer 






Fig.1-1: Gross anatomy of the spinal cord. (A) The spinal cord is a long, tubular 
bundle of nervous tissue and cells that is located inside the vertebral canal and is 
generally divided into cervical, thoracic, lumbar and sacral segments. Each 
segment has nerve fibers entering and exiting the spinal cord that are 
subsequently connecting to different parts of the body. (B) The spinal cord is 
arranged with white matter on the outside and a butterfly shaped gray matter in 
the center. The gray matter is subdivided into dorsal horns and ventral horns. 
Dorsal horns contain groups of sensory neurons, whose axons receive stimulus 
information from different parts of the body Ventral horns contain groups of motor 
neurons, whose axons exit spinal cord and innervate skeletal muscles. (C) The 
white mater surrounding the gray matter is divided into dorsal, ventral and lateral 
columns. Each of these columns includes a variety of nerve fiber tracts that 
contains ascending sensory (shown in blue) or descending motor axons (shown 















































average age of people at time of injury was 28.7 years old, whereas now this 
number has increased to 39.5 years old due to an increasing average population 
age. More than 2/3 of SCI patients are males. Motor vehicle accidents are 
reported to be the most common cause, which accounts for more than 40% of 
injury incidences, followed by falls (27%) and violent acts (15%). Depending on 
the severity of the injury, SCIs are categorized into tetraplegia or paraplegia. 
Over 50% of patients with SCI suffer from tetraplegia. Patients with tetraplegia 
often have sustained injuries to their cervical segments, which results in the 
partial or total loss of the use of their limbs and torso. Paraplegia is relatively less 
severe and patients often maintain the control to their arms. The life expectancy 
of patients following SCI at high cervical segment levels is reduced by 20 years 
when compared with healthy people. The severity of the injury also is related 
directly to lifetime costs. The average cost for the first year for patients with the 
most severe tetraplegic injuries (at C1-C4 level) is close to 1 million dollars, with 
an additional $200,000 dollars spent every subsequent year. The total annual 
cost of SCIs is estimated to be more than 9 billion dollars, including 
approximately 2.5 billion dollars contributed by lost productivity [117].  
 
1.2 Temporal Pathological Events Following Spinal Cord Injury  
 
A series of pathological events, including blood-spinal cord barrier 
destruction, different types of inflammatory cell infiltration and glial scar formation 
take place at the lesion site following SCI. These cellular and molecular 
responses play important roles that affect the subsequent regenerative phases of 










Table 1.1: Temporal Events Following SCI 
 
Stage                  Events                                                                References 
(time) 
Acute        Vasculature damage                                                           [1,3,4,5,7] 
(0-24 hrs)      -plasma protein extravasation 
                      -blood-spinal cord barrier permeability alteration 
                   Spread of vascular hemorrhage                                                  [1,2] 
                   Recruitment of inflammatory cells                                      [11,16,17] 
                   Edematous condition of surrounding tissue                             [11,17] 
                   Glial cell and neuronal cell necrosis (mechanical damage] 




Subacute               
(1-14 days)  Blood-spinal cord barrier permeability alteration and                [1,4,5] 
                    restoration of blood-spinal cord barrier  
                    Decrease of vasculature density                                         [8,10,11] 
                    Increase of vasculature density                                           [9,10,11] 
                    Secondary elevation of plasma protein extravasation                    [7] 
                    Astrogliosis and accumulation of inhibitory ligands  [30,32,41,44,48]  
                    Activated microglia become phagocytic                        [11,15,17,19] 
                    Hematogenous macrophage and lymphocyte infiltration              [19] 
                    Cytokine and growth factor upregulation                               [60-62] 
                    Secondary injury (glial cell and neuronal cell apoptosis)        [15,16] 
 
 
Chron ic    B lood-sp ina l  cord  bar r ie r  permeab i l i t y  a l te ra t ion  and                           
(weeks-         restoration of blood-spinal cord barrier                                           [6] 
months)        Cystic cavity formation                                                               [1-3] 
                      Decrease of vasculature density due to cavity formation    [8.10.11] 
                      Reduction in number of activated microglia/macrophage       [16,19] 
                      Glial scar maturation                                                                    [32] 
            Accumulation of scar-associated ligands                [30,32,41,44,48] 












Fig. 1-2: Temporal pattern of the pathological events following spinal cord injury. 
Adapted from [118]. 
 
 
1.2.1 Vascular Events Following SCI 
 
Following SCI, the integrity of the spinal cord vasculature is compromised 
due to the primary mechanical impact. Not only does the mechanical insult 
destroy blood vessels located in the lesion site, it also induces a series of events 
affecting surrounding intact vasculature, including alternation of blood-spinal cord 
barrier permeability and extravasation of plasma components into adjacent spinal 
cord tissue. The exposure of plasma derived cells and soluble molecules to 





early hemorrhage is often closely associated with the evolution of secondary 
damage and cystic cavities at chronic healing stages [1-3]. 
The alteration of blood-spinal cord barrier permeability following injury has 
been studied by different vascular tracers such as I125-labeled albumin or 
horseradish peroxidase (HRP) [1, 4, 5]. Acutely, maximal plasma protein 
extravasation has been reported to occur approximately 2 hrs following contusive 
SCI where a roughly 20-fold higher protein extravasation rate was observed over 
control animals. As blood vessel integrity is progressively restored, the 
extravasation rate has been reported to gradually decline to a roughly 3-fold 
increase 24 hrs following injury [4].  
In a transection SCI model, HRP reactivity showed that vascular 
hemorrhage extended both caudally and rostrally as far as 1cm away from the 
lesion site during the first several hours [5]. At 1 day postinjury, while the 
hemorrhagic pattern was similar to that of the first several hours, an asymmetric 
HRP reactivity with a more severe hemorrhagic response seen distal to the injury 
site caudally has been reported [5]. One to two weeks following injury, the blood-
spinal cord barrier leakage was restored and little to no HRP reactivity in the 
spinal cord tissue was observed. As the severity of the injury increased, HRP 
reactivity showed that the hemorrhagic area spread from the spinal cord grey 
matter to surrounding white matter and coincided well with the later cystic cavity 
development [1, 2] 
In contrast to the studies where HRP injection demonstrated that leaky 







that blood-spinal cord barrier remains leaky for at least 28 days when a small 
vascular tracer, [14C]--aminoisobutyric acid (AIB), is used [6]. Interestingly, a 
larger permeability change in grey matter than white matter is observed during 
the first week; however, the pattern is reversed 14-28 days following injury. This 
higher permeability in white matter at 14-28 days has been found to be in 
association with a secondary elevation of AIB transfer. A similar biphasic 
elevation of vascular tracer transfer has also been reported in a mice contusive 
SCI model [7]. The most pronounced extravasation of another commonly used 
vascular tracer, Luciferase, has been noticed as early as 35 mins after injury and 
then gradually decreases. A second elevation is found at 3-7 days and the barrier 
leakage is restored at 21 days postinjury[7].  
Although the majority of blood vessels in the lesion site are destroyed after 
traumatic impact, the regenerative phase of vasculature occurs rapidly. The 
number of blood vessels at the injury site has been found to be greatly 
diminished the first 1-2 days postinjury [8]. Regenerative vascular sprouting and 
immature capillary formation are then initiated from existing vessels [9]. A 
significant increase of vessel number has been seen at 3-4 days in the injury 
epicenter and some vessels have been found to be associated with invading 
astrocytes [8, 10, 11] Increasing astrocytes and blood vessel association have 
been observed between 4-7 days. After 7 days, blood vessel number 
redecreases due to cystic cavity formation and a dramatic decline has been 
shown to occur by 14 days [8, 10, 11]. More regenerating vessels are often seen 





have larger lumina and are frequently found to orient longitudinally across the 
lesion site [11]. In mice, significant regeneration and infiltration of blood vessels 
have also been reported to occur around 3-7 days; however, in contrast to rats, 
the vessel number remains afterwards without declining due to the fact that no 
cavity formation is associated with contusive injury in mice [7]. 
 
1.2.2 Inflammatory Response 
 
The inflammatory response following SCI involves a serious of cellular 
events. Different kinds of immune cells, including neutrophils, microglia, 
hematogenous monocytes/macrophages and lymphocytes, all play an important 
role in the natural defensive mechanism following SCI. They remove invading 
foreign materials and cellular debris at the injury site through secretion of reactive 
oxygen species, proinflammatory cytokines and proteases [12]. In addition to 
their active roles in sanitizing the injured tissue environment, they also secret a 
variety of antiinflammatory cytokines and growth factors which facilitate the 
postinjury regenerative processes by either promoting cell survival or modifying 
the extracellular environment to make it proregenerative [13, 14]. However, the 
interactions between the pro/antiinflammatory responses are often unbalanced 
with the proinflammatory response being the dominant player. This phenomenon 
then leads to the development of an inflammation-mediated secondary injury that 
exacerbates the initial direct mechanical trauma and contributes to delayed cell 
death and massive enlargement of the lesion area [15, 16].  
In animal studies, neutrophils have been reported to be the first immune 





injury site as early as 1 hr following injury, although in a very small number, 
probably as a result of mechanical damage to the blood vessels [16]. Typically at 
this time point, the adjacent tissue appears to be edematous [11, 17]. Numerous 
neutrophils have been found adhered to the inside blood vessel walls in the 
wound area 4-6 hrs after injury and very few are present extravascularly. The 
number of neutrophils present at the injury site has been shown to largely 
increase 6 hrs postinjury. As the infiltration of neutrophils continues, their 
numbers peak around 24 hrs. The neutrophil number then gradually decreases 
after 1 day and activated microglia and macrophages become the dominant cell 
type seen at the lesion site, taking over the defensive role. Very few neutrophils 
are still seen 3-4 days postinjury[16]. Similar to rodent injury models, the 
neutrophil infiltration following human SCI is also observed several hours 
following injury, peaking around 1 day, gradually decreasing afterwards and 
eventually disappearing within the first week [18]. 
Activated microglia and hematogenous macrophages replace neutrophils 
and become the major inflammatory cell types at the injury site approximately 3 
days postinjury [11, 16, 17]. Microglia are the resident macrophages of CNS 
tissue and are usually maintained in a resting state with highly ramified 
morphology. They are highly sensitive and can be activated within a short period 
of time after injury [18]. As early as 1 hr following injury, microglia have been 
found to shorten and thicken their processes, a sign of microglia activation. 
However, at this early time point, microglia cell body transformation from an 





stained for OX42, is not strongly stained with antisera against a lysosomal 
marker CD68 [16, 19] The activation state of microglia continuously increases 
during the first 24 hrs and many mononuclear cells appear at the injury site after 
2 days. Zhang and colleagues have reported that activated microglia transformed 
into a phagocytic phenotype 2 days following injury [11]. At 3-7 days, these 
CD68+ cells are the predominant cell type in the lesion area [11, 15, 17, 19]. In 
addition, a bulk infiltration of activated monocytes and macrophages has also 
been found at 7 days following injury [11, 19]. 
Subchronically to chronically, Popovich and colleagues have found that 
the activation state of activated microglia and macrophages at the lesion site 
plateaus between 2 and 4 weeks, then gradually decreases after 1 month to a 
level similar to 14 days postinjury in rat contusive SCI [19]. Activated microglia 
and macrophages have also been reported to progressively disappear from the 
injury site between 2 weeks and3 months following partial transection SCI [16]. 
Zhang and colleagues, on the other hand, observed a great number of 
macrophages remaining in the primary lesion site even at 6-8 weeks following 
crush injury [11]. 
In humans, Fleming and colleagues have reported that the transformation 
of resting microglia into activated microglia starts at 1-3 days postinjury [18]. 
Similar to rodent models, the morphology of activated human microglia shift from 
ramification to an amoeboid shape with enlargement of cell bodies, and 
thickening, as well as shortening of their processes. Hematogenous monocytes 





macrophage phenotype occurred roughly at the same time. Around 5-10 days 
following injury, numerous CD68+ cells were found in necrotic areas and CD68+ 
immunoreactivity remained significantly elevated weeks to months following 
injury [18].  
In rodents, lymphocytes infiltrate the lesion site following a similar 
temporal pattern as activated macrophages. The number of lymphocytes has 
been reported to significantly increase at 3 days following injury, peak around 1 
week and then gradually decrease afterwards. In particular, the distribution of 
lymphocytes has been found to concentrate more in the injury epicenter and to a 
lesser extent in the nearby lesion extensions [19].  
The temporal profile of lymphocyte recruitment differs in human patients 
compared to animal models. In human patients, only a limited number of 
lymphocytes have been observed extravascularly in the haemorrhagic and 
necrotic area up to 10 days after injury [18]. However, after this initial period the 
number of lymphocytes increases from weeks to months in humans.  
 
1.2.3 Glial Scar Formation 
 
In the spinal cord, the trajectories of ascending sensory fibers and 
descending motor fibers extend along white matter fiber tracts paved by 
longitudinally aligned glial cells [20-23] (Fig.1-3:A). Following SCI, the 
subsequent cellular and molecular responses interrupt the continuity of the 
organized glial framework and lead to the formation of a dense cellular structure, 
termed the glial scar [15, 20, 24]. The glial scar is a highly disorganized cellular 





The glial scar can be anatomically identified by increased expression of 
glial fibrillary acidic protein (GFAP), an intermediate filament found exclusively in 
astrocytes[25-27], as well as other intermediate filament proteins such as 
vimentin [28, 29]. The GFAP and vimentin expression are generally observed to 
be upregulated during the first week following SCI [19, 30-32]. This upregulation 
is initially seen at the injury core and subsequently spreads both caudally and 
rostrally [33]. This spread of the reactive astrocyte response away from the injury 
site has been correlated with animal maturity. Extensive astrogliosis and long 
distance spreading into adjacent spinal cord segments has been observed in 
adult animals following injury whereas the reactive astrocyte response in 
neonatal animals is mild and confined to the injury site [33]. In addition, the 
GFAP upregulation has been found to be region-dependent where more GFAP+ 
reactive astrocytes are seen in spinal cord segments proximal to the injury center 
than distal segments and persisted for at least 30 days [30]. 
Depending on the nature of the injury, the lesion center can either form a 
necrotic core surrounded by a rim of reactive astrocytes or eventually become 
filled by them [15, 17, 19]. Although the reactive astroglial responses take place 
acutely after injury where the increased mitotic activity and the hypertrophy of 
reactive astrocytes become noticeable within 7 days, the maturation of the glial 
scar may take several months to accomplish [32] (Fig. 1-3:B, C, D and E). In 
cases of laceration of penetration SCI where the continuity of dura mater breaks 
down, the glial scar also contains connective tissue elements derived from 







Fig. 1-3: Inhibitory glial scar formation. (A) In the spinal cord, the fiber tracts are 
paved by longitudinally oriented astroglial cells. Here, a network of organized 
astrocytic processes, visualized by GFAP, is found lining along the corticospinal 
motor fiber tract. The development of the glial scar at (B) 1, (C) 3, (D) 7, and (D) 
13 weeks. The glial scar formation is a hallmark cellular response following SCI 
and a mature scar may take months to form. Adapted from [32] (D) The glial scar 
is repulsive to axonal regeneration due to both its disorganized cellular structure 
and associated inhibitory ligands. GFP labeled DRG axons (shown in green) 
have been shown to stall at the margin of the scar tissue (stained for chondroitin 
sulfate proteoglycan (CSPG) in red). Adapted from [24]. Scale bar=50 μm in (A), 
100 μm in (B-E), 250 μm in (F). 
 
 
In contrast to the strong astrogliosis reaction seen in rodent SCI models, 
the reactive astroglial response in humans is not only delayed by 4 months 
following injury but also accompanied with only slight GFAP upregulation. The 
intensity of GFAP immunoreactivity decreases to a level lower than normal spinal 
cord by 1 year following injury and persist for 23 years [18]. 
The glial scar is considered the major impediment for axonal regeneration 
as many in vivo studies have established the close association between axonal 
regeneration failures and scar formation [15, 20, 24, 36] (Figure 1-3:F). 





are incapable of penetrating though the entire scar territory. The glial scar was 
originally thought to act simply as a physical barrier impeding axonal 
regeneration [37-39]; however, recent studies have demonstrated that the 
molecular composition of the scar tissue also contributes to its inhibitory nature 
[40-42]. These putative inhibitory molecules include subtypes of chondroitin 
sulfate proteoglycans (CSPGs) [43-46] and tenascins [42, 47] that are secreted 
by activated glial cells, as well as myelin associated molecules [48-50] which are 
expressed by cells of oligodendrocytes lineage or exposed due to myelin sheath 
damage. Semaphorin and deposited collagenous materials have also been 
shown or suggested to contribute to the inhibitory nature of the glial scar when 
there is meningeal fibroblast infiltration following SCI [34, 35, 51]. 
 
1.3 The Protective Role of Astrocytes Following Spinal Cord Injury 
 
As mentioned previously, reactive astrogliosis is a prominent cellular 
feature following SCI and the inhibitory effect of the astroglial scar on axonal 
regeneration has been well established both in vitro and in vivo [20, 24, 40, 41, 
45]. However, recent studies have started to reveal the positive roles of reactive 
astrocytes following SCI. Astrocytes play important housekeeping roles as they 
scavenge excess extracellular glutamate and ions to prevent excitotoxicity, 
maintain homeostasis and secrete a variety of neurotrophic factors that are 
essential for neuronal activities [52-56]. Following injury, the expression of 
astrocyte associated glutamate transporters has been shown to upregulate in 
response to the elevated extracellular glutamate level due to neuronal 





reactive astrocytes after injury demonstrated a down-regulation of available 
glutamate transporters, which in turn resulted in neuronal degeneration similar to 
the pathology of direct excitotoxicity induced by excess glutamate [58]. These 
results suggest that even in an activated hypertrophied state, reactive astrocytes 
continue regulating the extracellular glutamate level to prevent neuronal toxicity. 
In addition, astrocytes sustain metabolic homeostasis by storing energy in the 
form of glycogen and their metabolic activities become hyperactive following 
injury, which metabolize stored glycogen to provide energy for surviving neurons 
[59]. 
Reactive astrocytes also continue providing trophic support essential for 
the neuronal survival in the vicinity of the injury site [53-56]. Following exposure 
to proinflammatory cytokines, such as interleukin-1 beta (IL-1) and interleukin-6 
(IL-6), reactive astrocytes have been shown to increase the production of nerve 
growth factor (NGF), fibroblast growth factor-2 (FGF-2) and neurotrophin-3 (NT-
3), which all are important for neuronal survival or regeneration [60, 61]. 
Additional to the beneficial effects on surviving neurons, reactive astrocyte 
secreted vascular endothelial growth factor (VEGF) promotes angiogenesis and 
revascularization, which are essential for nutrient and oxygen transport and 
wound healing [55]. Insulin growth factor-1 (IGF-1), secreted by reactive 
astrocytes as a result of IL-1 signaling, regulates oligodendrocyte precursor 
proliferation and maturation into myelin synthesizing mature oligodendrocytes, 





Although at the chronic stages, disorganized scar tissue has been clearly 
demonstrated as an obstacle to axonal regeneration, acutely the scar tissue 
demarcates a boundary separating the lesion area and surrounding healthy 
tissue, suggesting a potential role of reactive astrocytes in regulating the spatial 
distribution of these inflammatory cells and preventing adjacent tissue damage 
[63]. In particular, reactive astrocytes play an important role in restoration of 
disrupted blood-spinal cord barrier and reestablishment of extracellular 
homeostasis, both are critical for proper neuronal functions [58, 63]. As shown in 
the transgenic mice studies where reactive astrocyte proliferation is ablated, 
animals without reactive astrocyte proliferation are associated with more severe 
hemorrhage, tissue destruction and increased cell death [63, 64]. The reactive 
astrocyte infiltration into lesion center has also been demonstrated to result in 
improved locomotor recovery [65, 66]. 
It was proposed by Rolls and colleagues [67] that the process of reactive 
astrogliosis could be divided into two phases, a first (early) phase where reactive 
astrocytes contribute positively to preserve tissue function and a second (chronic) 
phase where a mature, disorganized glial scar forms and inhibits axonal 
regeneration. Therefore, therapeutic interventions that could modify the glial scar 
formation during the acute to subacute phases (~weeks) to make the scar tissue 
more proregenerative at the chronic stage could be promising for SCI repair. 
 
1.4 Astroglia Mediated Neuronal Outgrowth 
 
A rich body of evidence has demonstrated that astroglia cells actively 







support or provide guidance to either pioneering axons during development or 
regenerating axons following injury [24, 68-75]. The underlying molecular and 
cellular mechanisms by which astroglia support and guide neuronal pathfinding 
have been elucidated by many in vitro and in vivo studies [74, 76-82]. It has been 
shown that astroglia deposit or express a variety of permissive molecules, 
including laminin (LN), fibronectin (FN), N-Cadherin and neural cell adhesion 
molecules (NCAM), that contribute to neuronal pathfinding by providing an 
























Fig. 1-4: Astrocytes support neuronal cell outgrowth in vitro. (A) Dissociated DRG 
neurons (shown in red) extend lengthy neurites on astrocyte monolayers (stained 
for GFAP in green) in vitro. Various astrocyte associated permissive ligands, 
such as FN (green in B), LN (green in C) and NCAM (green in D) have been 
shown to act as permissive substrates in supporting neuronal cell outgrowth (red 






The expression of LN, one of the major axonal growth promoting 
molecules expressed by astrocytes, has been shown to precede and closely 
associate with pioneering axon entry into the optic nerve in the optic nervous 
system development [76]. Punctate patterns of LN immunoreactivity have also 
been found at the marginal area of the ventral longitudinal pathway in the mouse 
embryo and in close association with invading axons [77]. In addition to serving 
as a guidance cue, astrocyte associated LN has also been shown to be an 
important ligand for that provides a permissive substrate to support neuronal 
outgrowth in vitro [81].  
FN is another astrocyte derived permissive extracellular matrix (ECM) 
protein that supports neurite outgrowth and studies have revealed at least 2 
binding sites on FN molecules that interact with central nervous system (CNS) or 
PNS neurons with different affinities [83, 84]. In addition, astrocyte derived FN 
have been shown to be critical for sensory fiber regeneration in the adult rat 
white matter [74]. The role of astrocyte associated FN in guiding neuronal 
pathfinding has also been suggested in vitro using confocal microscopy where 
regenerating dorsal root ganglion (DRG) neurites were found to be closely 
associated with linear arrays of astrocyte derived FN bundles [85]. 
N-cadherin and NCAM are two membrane-bound axonal growth 
promoting ligands expressed by astrocytes whose roles in guiding axonal 
outgrowth along astroglial cells have been revealed in vitro[78, 80]. Functional 
antisera blocking N-cadherin and 1 ECM receptors has been found to reduce 





the important role of Ca2+ mediated cell surface molecules and ECM proteins in 
supporting neurite outgrowth at early developmental stages. NCAM, on the other 
hand, has been shown to regulate mature retinal neuron neurite outgrowth (E14) 
on astrocytes [78]. In contrast to retinal neurons, NCAM is not involved in 
mediating ciliary ganglion neuron neurite outgrowth whereas N-cadherin plays an 
important role in regulating both E8 and E14 ganglion neurons [80]. 
In addition to guiding axonal pathfinding via expression of permissive 
ligands, astroglia are recognized to deposit inhibitory ligands to form molecular 
boundaries for regulating neurite trajectories and patterning. CSPG is the major 
repulsive ECM molecule deposited by astrocytes. This inhibitory ligand has been 
shown to serve such a function both in vivo and in vitro[42, 86-88]. During 
development, the deposition of CSPG-rich territories by astroglial cells is 
believed to form repulsive barriers restricting axonal infiltration into unwanted 
areas. The functional role of CSPG-rich molecular barriers in organizing axonal 
growth patterns is demonstrated by an experiment utilizing chondroitinase ABC 
(ChABC), an enzyme that digests away the glycosaminoglycan (GAG) chains 
attached to the CSPG core protein. Injection of ChABC into developing zebrafish 
embryo has been found to induce abnormal ventral motor axonal outgrowth and 
branches formation [89]. In vitro, neurite trajectories on astroglial surfaces have 
also been observed to avoid regions rich in CSPG [42, 86]. 
 
1.5 Astrocyte Transplantation for Central Nervous System Repair 
 
Numerous studies have shown that astrocytes are permissive substrates 





81]. However, this supportive ability of astrocytes has been shown to be 
dependent on their maturation state [79, 90]. As astrocytes age in vitro, they 
gradually become less permissive as the result of the altered molecular basis 
underlying astrocyte-neuron interactions [79]. Moreover, insoluble factors derived 
by mature astrocytes have been suggested to be the critical factors that 
contribute to the reduced permissiveness to support neurite outgrowth [90].  
Contrary to the decreased permissiveness of aged astrocytes to support 
neurite outgrowth, studies have found therapeutic potential for immature 
astrocytes in CNS injury repair applications [91-97] (Fig. 1-5). When young 
astrocytes (i.e., 4 days in culture) coated nitrocellulose grafts are implanted into 
adult mice forebrain, it suppresses glial scar formation and implanted young 
astrocytes are able to migrate away from the graft and integrate with the 
surrounding CNS tissue. On the other hand, aged astrocyte (i.e., 28 days in 
culture) coated implants are associated with intense glial scar formation and little 
integration between the grafts and the host tissue is seen [94]. Embryonic 
astrocyte coated polymer implants have also been applied at injured dorsal root 
entry zone to facilitate dorsal root nerve fiber regeneration [92]. Similarly, these 
young astrocyte coated grafts are well integrated with adjacent spinal cord 
parenchyma and dorsal root fibers with varying degrees of regeneration back into 
the spinal cord are found in few animals. In the lesioned rat fornix fiber tract, 
transplantation of immature astrocyte suspensions results in a significant 
increase of myelinated axons seen proximal to the lesion site 8 weeks follow 





























Fig. 1-5: Transplantation of immature astrocytes for spinal cord injury repair. (A) 
Injection of GFP labeled immature astrocytes (IA, shown in green) in combination 
of ChABC (Ch’ase) promote regeneration of p75+ axons (shown in red) across 
the lesion site in a rat brain microlesion injury (asterisks). (B) ChABC injection 
effectively digests away the GAG chains on CSPG, confirmed by positive 2B6 
antisera detection (shown in red). Adapted from [97]. (C) Transplantation of 
astrocytes (shown in red) derived from glial restricted precursors cells promotes 
GFP labeled DRG axons (shown in green) regenerating across the lesion center 
and enter the rostral side of the host spinal cord tissue. Adapted from [75]. Scale 









suspensions, also has been demonstrated to induce increased number of 
neurofilament positive axonal fibers penetrating into the lesion site [95]. In 
addition, when incorporated in a collagen matrix, immature astrocytes have been 
shown to attract regenerating axons penetrating into the implant, but only to a 
limited extent [91]. Furthermore, transplantation of immature astrocyte in 
combination with ChABC treatment have been found to facilitate CNS axonal 
regeneration across the injury site in microlesioned cingulum [97].  
Recently, transplantation of a specific type of astrocyte derived from 
embryonic glial restricted precursor has been shown to greatly benefit the 
regeneration outcome following unilateral transection SCI in rats [75]. These glial 
restricted precursor derived astrocytes (GDA) are generated by exposing 
precursor cells to bone morphogenetic protein-4 (BMP-4) in vitro and are able to 
promote extensive axonal regeneration in vivo and functional recovery. Injured 
animals that receive GDA transplantation achieve indistinguishable outcomes in 
the volitional foot placement test when compared to uninjured rats [75, 98]. 
In particular, transplantation of GDA induced a significant realignment of 
the reactive astrocytes around the lesion border where the usually seen 
misaligned glial scar tissue is replaced by organized arrays of astrocytic 
processes parallel to the normal spinal cord rostral-caudal axis [75, 98]. This 
aligned astrocyte framework has been suggested to at least partially contribute to 
the observed extensive axonal regeneration since growth cone pathfinding would 
be more efficient when exploring a maze of misaligned reactive astrocytic 





1.6 Organized Glial Structure for Axonal Guidance  
 
During CNS development, pioneering axons extend a long distance 
toward their targets through interactions with a variety of directional cues and a 
part of the directional information is provided by interacting with surrounding 
astroglial cells. The astroglial cells crosstalk with pioneering axons temporally 
and spatially by organizing into organized glial frameworks and extending their 
processes parallel to the presumptive fiber tracts at specific periods during 
development [68-73, 99-101]. 
In the developing chick retina, Mller cells (i.e., astroglia in the retinal 
system) have been shown to arrange their endfeet to form organized cellular 
tunnels filled with axons, suggesting their role in organizing and directing retinal 
axonal outgrowth [101]. A similar close association of Mller cells to the optic 
axons in the developing mice retinal system has also been demonstrated [101]. 
In addition, GFAP+ astroglia have been reported to form organized glial 
structures preceding the arrival of callosal commissural axons during the fusion 
of two brain hemispheres [71]. Moreover, it has been shown that during midline 
decussation, commissural fibers interact with GFAP+ cells and their processes in 
the formation of anterior commissure [73]. Organized astroglia patterns have also 
been found in the adult mouse and rat spinal cord, being parallel to the neuronal 
processes [100, 102].  
Following SCI, available evidence has suggested that an organized glial 
structure could be utilized by regenerating axons as supporting scaffolds to 












Fig. 1.6: Organized glial frameworks facilitate axonal regeneration. (A) 
Transplanted GFP labeled DRG neurons (shown in green) showed robust and 
long distance outgrowth in degenerating spinal cord white mater. (B) In particular, 
these GFP+ axons (shown in green) are found to be in a close association and 
growing parallel to the longitudinally aligned host astrocytic processes (shown in 
red) Adapted from [24]. (B) Following olfactory ensheathing cell transplantation, 
the astrocytic processes (shown in red) and Schwann cell processes (shown in 
green) at the injury interface are found to form ladder-like, parallel bridging 
structures that aligned in the normal oblique orientation of dorsal roots. (D) 
Regenerating sensory fibers (shown in red) follow the oriented glial cell 
processes at the interface and cross the lesion site. OECs are shown in green 
and DAPI is used as counterstain. Adapted from [105]. (E) GDA transplantation 
reorganize the reactive astrocyte processes at the lesion margin and 
regenerating DRG axons (shown in green) are found to follow the oriented 
astrocytic processes at lesion margin (shown in red) penetrating into the lesion 
center. Adapted from [75]. Scale bar=500 μm in (A), 50 μm in (B),100 μm in (C), 









of DRG neurons transplanted into degenerating adult rat spinal cord have been 
found to extend long distances parallel to, and closely associated with, 
longitudinally aligned host astrocytic processes. This robust outgrowth is found to 
stall when regenerating axons enter the disorganized glial scar territory [24]. 
Similar neuronal outgrowth patterns that followed the processes of host 
astrocytes have also been observed when different types of embryonic neurons 
are transplanted into myelinated adult rat fiber tracts [107]. In addition, when 
cultured on tissue slices containing corpus callosum, a white matter fiber tract in 
the brain, DRG neurites also generally extend along GFAP+ astrocytic processes 
[74]. The regenerating endogenous rubrospinal motor fibers have also been 
found to follow the orientation of realigned reactive astrocytic processes at the 
lesion margin, which then penetrated into the lesion center [75, 98]. 
The hypothesis that an organized glial structure could potentially facilitate 
axonal regeneration is reinforced by transplantation studies of olfactory 
ensheathing cells (OECs) [103, 105, 108]. In injured dorsal root entry zones, 
transplanted OECs have been found to induce a ladder-like bridging structure, 
established by host CNS astrocytic processes and PNS Schwann cell processes. 
Regenerating sensory fibers are found to extend across the injury site in 
alignment with these oriented glial processes at the interface [105]. OECs 
transplantation has also been shown to induce regenerating corticospinal tract 
axons advancing through the transplant and back into host spinal cord tissue 
without interruption [103]. The fact that OECs can reorganize the configuration of 





to be one of the underlying cellular mechanisms by which OECs facilitate 
regeneration [108]. Longitudinally oriented axons have also been observed to be 
associated with organized Schwann cell frameworks that infiltrated into the lesion 
site following rat contusive SCI, reinforcing the idea that organized glial 
structures direct and facilitate axonal regeneration [104]. 
 
1.7 Engineering Oriented Glial Framework In Vitro 
 
Given the knowledge that astroglia guide neuronal pathfinding via 
formation of organized glial structures and deposition of both permissive and 
repulsive ligands, it is intriguing to think that axonal regeneration could be 
supported, promoted and directed if an oriented glial substrate were able to be 
engineered to restore the organized glial framework at the injury site. 
Mechanical cues such as topographical grooves have been shown to 
successfully induce alignment of different glial cell types in vitro [85, 109-114] 
(Fig. 1-7). Substrates containing microgrooves made of poly (D,L-lactic acid) 
have been fabricated and coated with LN to align Schwann cells in vitro[112]. 
The groove width is found to be the critical parameter in inducing Schwann cells 
organization rather than the depth of the grooves. In particular, groove width 
falling into the 10-20 μm range, slightly larger than the width of a Schwann cell 
body, is demonstrated to be optimal. When rat spinal neurons are cultured atop 
the aligned Schwann cell monolayers, neurite trajectories are found to be parallel 
to the orientation of underlying Schwann cells, presumably guided through both 

















Fig. 1-7: Oriented astrocyte monolayers guide neurite outgrowth in vitro. (A) No 
biased neurite outgrowth is observed when DRG neurons are cultured on 
randomly organized astrocyte monolayers. (B) Directed neurite outgrowth is 
observed when DRG neurons are cultured on oriented astrocyte monolayers 
induced by grooved substrates. (C) Similar guided outgrowth behavior is also 
observed with adult DRG neurons. (D, E) Reconstructed 3D confocal images 
confirm neurite outgrowth atop astrocyte monolayers. Adapted from [85]. 
Neurites are shown in red and astrocytes are shown in green in (A-E). Scale 














Organized astrocyte frameworks have also been successfully engineered 
in vitro [85, 109, 113-115]. Oriented astrocyte monolayers are engineered by 
culturing primary rat cortical astrocytes on grooved polystyrene substrates [85]. 
The roughness of surface undulation has been shown to play an important role in 
organizing astrocyte orientation and a threshold value must be achieved in order 
to provide directional information. Aligned astrocyte monolayers successfully 
direct adjacent regenerating DRG neurite outgrowth in a direction parallel to the 
orientation of astrocytic processes, irrespective of the developmental stage of the 
neuron. In addition, the spatial pattern of various astrocyte associated ligands is 
found to be related to astrocyte morphology such that a network of corresponding 
insoluble ligands (i.e., ECM proteins and membrane bound molecules) is 
observed to be present anisotropically on aligned astrocyte monolayers. In 
particular, confocal microscopy reveals a close association between the 
trajectories of regenerating DRG neurons and linear arrays of astrocyte derived 
FN, suggesting a potential role of FN in guiding DRG pathfinding. The directed 
outgrowth length (i.e., neurite outgrowth in a particular direction of interest) of 
neurites grown on aligned astrocyte structure is found to be significantly 
increased when compared to those grown on randomly organized astrocytes [85]. 
Similar astrocyte alignment is also achieved on micropatterned polystyrene 
substrates [113]. It has been shown that astrocyte alignment induced by 
microtopography can be maintained for at least 3 weeks in vitro [114]. Although 
neurite alignment on oriented astrocyte monolayers engineered by 





polymeric substrates, neuronal survival on the astrocyte coated substrates is 
significantly prolonged [114].  
Astrocyte alignment has also been successfully induced by the application 
of external electric fields in the absence of physical cues, which then guide the 
directional outgrowth of regenerating DRG neurons [109]. Moreover, it is 
demonstrated that directed neurite outgrowth is maintained even when neurons 
are grown on fixed, oriented astrocyte monolayers, suggesting the insoluble 
ligands derived from astrocytes play the critical role in mediating neurite 




In summary, a large body of evidence has suggested the beneficial roles 
of astrocytes following SCI. Astrocytes are the critical player in maintaining ion 
homeostasis, regulating extracellular glutamate level, reestablishing the blood-
spinal cord barrier integrity and restricting the spread of infiltrating inflammatory 
cells into healthy tissues following injury. In addition, they secret neurotrophic 
factors that support the survival of neuronal cells postinjury. Although reactive 
astrocytes are known to be the major component of the inhibitory glial scar, 
studies have also shown that they can be proregenerative following exposure to 
postinjury cytokines.  
In addition, rich evidence has suggested that the regenerative ability of 
injured axons could be promoted when an organized astrocyte framework is 
provided. Regenerating axons have been found to be able to retrieve directional 





trajectories, potentially through interactions with a network of anisotropically 
organized ligands expressed and deposited by astrocytes, both permissive and 
repulsive. Particularly, astrocyte derived FN might be a potent guiding ligand as 
neurite trajectories were found to be directly atop of linear bundles of astrocyte 
derived FN in vitro. 
However, there are still questions that remain to be asked in order to get a 
more complete understanding of the underlying molecular mechanism that 
oriented astrocytes guide neuronal pathfinding, and how to translate this 
knowledge to develop novel biomaterials to improve current treatments. Although 
Biran and colleagues observed a close association between linear arrays of 
astrocyte derived FN and DRG neurites, the fact that the culture system was 
based on grooved substrates makes it difficult to rule out the involvement of the 
mechanical effect on influencing neurite trajectories. Similarly, Alexander and 
colleagues failed to demonstrate what the key insoluble ligand(s) on aligned 
astrocyte monolayers provides the directional information for adjacent neuronal 
cells. Moreover, despite studies that have demonstrated the feasibility of 
engineering aligned glial structures in vitro to induce directional axonal 
regeneration, it is unclear if an oriented glial framework could be transferred for in 
vivo applications. Our studies were designed to investigate these unanswered 
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INDUCING ALIGNMENT IN ASTROCYTETISSUE CONSTRUCTS BY  
 







The ability of astroglia to guide neuronal pathfinding during development, 
 
in vitro and following injuries is well established. During development, astroglia 
provide directional information to pioneering axons by organizing into glial 
frameworks or boundaries at specific periods [1-6]. In addition, available 
evidence indicates that regenerating axons extend long distances following 
longitudinally aligned glial cells [7-11]. In vitro, various studies have shown that 
astrocytes and their secreted extracellular matrix (ECM) support neurite 
outgrowth of a variety of neuronal cell types [12-16]. In addition to acting as a 
permissive substrate, astrocytes also guide neurite extension through depositing 
inhibitory ECM [17-19]. 
Given the knowledge that astroglia serve as guidepost cells during 





understanding how regenerating axons interact with astroglia may shed light on 
developing new therapeutic approaches to reconstruct parts of the damaged 
nervous system or to bypass the disorganized astroglial scar. To facilitate 
functional recovery, severed and/or spared sprouting axons must reinnervate 
specific and not random targets so methods that allow control over the trajectory 
of regenerating axons may provide technology to enhance functional recovery 
[23]. 
Several groups are studying how to engineer oriented glial substrates to 
study the underlying cellular and molecular mechanisms by which glial cells 
guide neuronal pathfinding [24-27]. It was previously demonstrated that oriented, 
engineered astrocyte substrates are useful for enhancing directed neurite 
outgrowth [25, 26, 28]. In one approach, topographical grooves and indentations 
in growth culture substrates have been used to orient astrocyte morphology [25, 
26, 29]. Nerve cells plated on top of the directionally oriented astrocytes extend 
neurites in the same direction as the underlying oriented astrocyte monolayers 
[25, 26]. However, using such an approach, it is not clear whether the 
architectural features themselves are responsible for the directional orientation of 
the overlying neurons as grooved substrates alone are effective in directing 
neurite elongation [30, 31]. 
To better elucidate the mechanisms involved in astrocyte mediated 
neuronal outgrowth, planar substrates with patterned nanometer–level 
anisotropic guidance cues were produced with soft lithographic methods in which 





of untreated glass (15 m wide). We used this approach to exclude the influence 
of physical undulations on directing neurite trajectories, and examined how 
engineered astrocyte constructs affect the directional outgrowth of adjacent 
regenerating neurites, as well as, how they affected the orientation of adjacent 
astrocytes in thick tissue engineered constructs. 
 
2.2 Materials and Methods 
 
2.2.1 Micropatterning Device Fabrication 
 
Polydimethylsiloxane (PDMS, R-2615, Nusil) contact printing stamps were 
designed using software L-edit and fabricated in the University of Utah 
Microfabrication laboratory. Stamps were designed to have anisotropic 
continuous lanes (15 m wide) interspersed with continuous bare coverslip 
surfaces (15 m wide) in order to provide directional information to align 
astrocytes. 
Photolithographic masks of the designed pattern were fabricated using a 
micropattern generator (Electromask). Resulting masks were used directly as 
molds to produce PDMS stamps. PDMS two component kit was mixed in a 1:10 
ratio, vacuumed treated to remove bubbles till no bubbles were observed, poured 
into a mold and then cured at 100°C for 30 mins. The cured PDMS stamps were 
peeled off against the mold and cut into approximately 1×1.5cm2 blocks. PDMS 
stamps were immersed in hexane overnight to remove residual uncured PDMS 








2.2.2 Microcontact Printing 
 
Glass coverslips were cleaned by rinsing with acetone, isopropanol 
followed by double distilled deionized (DD) water, then sonicated for 15 mins and 
autoclaved. Ten l laminin solution (LN, 400 g/ml in sterile PBS; Sigma) was 
applied to each PDMS stamp and covered by a coverslip to help the solution 
spread the entire stamp surface for 25 mins. After adsorption, stamps were 
rinsed with sterile DD water and briefly dried under a nitrogen stream. LN 
adsorbed stamps with and without a lane pattern were brought into contact with 
clean coverslips and then removed to generate both isotropic and anisotropic 
protein pattern. 
 
2.2.3 Astrocyte and DRG Isolation and Preparation 
 
Purified primary rat postnatal astrocytes were isolated as previously 
described [32]. Cerebral cortices from postnatal Day 1 (P1) Sprague–Dawley rats 
were dissected out with meninges removed, then minced and digested (1.33% 
collagenase, 30 mins, Worthington Biochemical) followed by 0.25% trypsin 
treatment (30 mins, Worthington Biochemical). The cells were triturated and 
suspended in DMEM/F12 medium (Invitrogen) with 10% fetal bovine serum (FBS, 
Atlantic Biological). The dissociated cells were plated in 75 cm2 flasks. After one 
week, purified astrocytes were obtained by overnight shake-off at 175 rpm. 
Dorsal root ganglion neurons (DRG) were isolated from P1 rats as previously 
described [23]. Individual neurons were removed from their location near the 
spinal column. Then the attached nerve roots were removed and the ganglia 





mins. The tissue was then triturated. The resulting cell suspension was 
centrifuged, suspended in 1 ml DMEM/F12 plus 50 l of DNase. Then 
dissociated DRG neurons were plated on astrocytes monolayers on various 
patterns in DMEM/F12 with 10% FBS. 
 
2.2.4 Astrocyte and DRG Culture 
 
Purified astrocytes were seeded on LN lanes patterned or onto 
homogeneous fields of LN surfaces at a density of 17,300 cells/cm2 in serum free 
medium (SATO-) over the first 4–6 hrs and then switched to 10% FBS for the 
remainder of the 4-day period to create confluent oriented and randomly, 
organized astrocytes monolayers, respectively. Medium was changed every 
other day. To produce fixed oriented and randomly organized astrocyte 
monolayers, astrocytes were cultured as described above and fixed by 
immersion in 4% paraformaldehyde for 15 mins after 4 days in culture. After 
fixation, cell layers were rinsed with sterile PBS once and then immersed in 
DMEM/F12 medium at 37°C for 2 days to remove and deactivate residual 
aldehyde groups generated during the fixation process. Fresh medium was 
changed every day. 
DRG neurons were seeded on both live and fixed astrocytes monolayer 
cultures (both oriented and randomly, organized) at a density of 580 DRG 
neurons/cm2 in 10% FBS supplemented with 10 ng/ml 2.5S nerve growth factor 
(NGF; Invitrogen). The co-cultures were cultured for an additional 48 hrs and 








Purified astrocytes were seeded on patterned (anisotropic) and 
unpatterned (isotropic) surfaces at a density of 52,000 cells/cm2 with serum free 
medium (SATO-) over the first 4–6 hrs and switched to 10% FBS for 2 days to 
create the first confluent, oriented and random astrocyte monolayers, 
respectively. Then, the seeding process was repeated every other day with 
52,000 cells/cm2 in 1.5 ml 10% FBS. Half of the culture medium in each well was 
replaced with fresh medium the next day following cell seeding. The seeding 
process was repeated 3–4 times to create multilayered astrocyte cultures, which 
were then fixed using 4% paraformaldehyde. 
 
2.2.5 Anti-FN Antisera Blocking Experiment 
 
Fixed oriented astrocyte monolayers were treated with mouse anti-FN 
antisera (45 g/ml, Sigma) for 3 hrs then rinsed with sterile PBS prior to adding 
dissociated DRG neurons. DRG neurons were seeded at a density of 580 DRG 
neurons/cm2 in 10% FBS, supplemented with 10 ng/ml 2.5S NGF. DRGs were 
cultured for an additional 48 hrs and treated with 4% paraformaldehyde for 15 
mins and then stored in PBS with azide. Untreated, fixed oriented astrocyte 
monolayers served as controls. There were four repeat experiments for each 
group. 
 
2.2.6 Immunohistochemistry and Image Acquisition 
For intracellular antigens, fixed cultures were treated with 0.05% Triton X-
100 in PBS for 5 mins and rinsed with PBS three times. No Triton was applied for 





layers were blocked with 4% goat serum and 0.1% sodium azide in PBS for 1 hr 
and incubated with primary antisera against glial fibrillary acidic protein (GFAP, 
DAKO, 1:1000), neurofilament (NF160, Sigma, 1:500), laminin (LN, Sigma, 
1:500), cellular fibronectin (FN, Sigma, 1:500), chondroitin sulfate proteoglycan 
(CS-56, Sigma, 1:500) and neural cell adhesion molecule (NCAM, Sigma, 1:500). 
Appropriate conjugated secondary antibodies (Molecular Probes) were applied at 
dilution of 1:500 except for GFAP (1:1000). All antibodies were diluted in 4% goat 
serum with 0.1% azide and applied for 24 hrs at room temperature. Fixed cell 
layers were rinsed with PBS three times both after primary and secondary 
antibody application. DAPI (10 M; Molecular Probes) was used for all cell nuclei 
visualization. Coverslips were mounted with Fluoromount–G (Southern 
Biotechnology). Images were acquired using a Nikon epifluorescence 
microscope equipped with a CCD camera or using an Olympus FVX laser 
scanning confocal microscope. 
 
2.2.7 Astrocyte Orientation Analysis 
 
The orientation of elliptical DAPI+ astrocytes cell nuclei was used to 
determine astrocyte orientation as well as their overall appearance. For 
astrocytes cultured on unpatterned LN surface, the vertical axis of each image 
was chosen as the reference axis. For astrocytes cultured on the patterned LN 
substrate, the long axis of the printed LN lane pattern was used as the reference 
axis for calculating cell orientation. A built-in function of ImagePro (Media 
Cybernetics) was used to generate elliptical outlines for all cell nuclei and the 





axis of the image was calculated. Nuclei that were cut off by the edge of images 
and clusters of nuclei that overlapped, which the program could not distinguish 
and recognize, were manually removed from the data set. Each measurement 
was placed into a data bin of plus or minus 10° off the designated axis of each 
image. Angle bins ranged from −90° to 90° with 0° being parallel to the 
designated vertical axis of each image. Four random images were taken from 
each coverslip and there were four repeats for each condition (oriented and 
random). 
 
2.2.8 Neurite Length and Alignment Quantification 
 
NF-160 antibody was used to visualize neuronal cell bodies and their 
processes. Neurite angle and length measurement were conducted using NIH 
Image J software. Directed length was measured and defined as the vector 
length of each neurite growing in the direction of interest. To calculate the 
directed length, a straight line was first drawn from the tip of the neurite to the cell 
soma. Then the directed length of each neurite was calculated by multiplying the 
length of the straight line by the cosine of the angle made between the straight 
line and the direction of interest. A designated axis of each image was chosen as 
the direction of interest for DRGs grown on astrocytes monolayers cultured on 
unpatterned substrates (both live and fixed) whereas the long axis of the LN lane 
pattern was used for DRGs grown on oriented astrocyte layers (both live and 
fixed). 
Orientation of neurite outgrowth was quantified by measuring the angle 





the reference axis. Each measurement was placed into a data bin of 10° ranging 
from −90° to 90° with 0° being parallel to the reference axis. There were three 
repeats for each condition (live random, fixed random, fixed oriented and live 
oriented). 
 
2.2.9 Multilayered Astrocyte Analysis 
 
Two dimensional fast fourier transform (FFT) has been used to analyze 
anisotropy in cells [24] and [61]. Multilayered astrocyte cultures (random and 
aligned) were stained for FN and the spatial distribution of astrocyte derived FN 
was used as an indicator for cellular orientation. Confocal microscopy was used 
to image through the thickness of the multilayered astrocyte cultures. Two 
dimensional FFT was applied on the z-stack images of both random and aligned 
multilayered cultures using NIH Image J software. The “Oval Profile” plug-in was 
used to determine radial sums over the 2D FFT image from 0° to 360° with 
discrete sampling of every 10°. These data were summarized so that the sum is 
unity. As the 2D FFT is symmetrical, only data points from 0° to 180° were used. 
It should be noted that the FFT image was first rotated 90° counterclockwise 
because the results of the FFT yield frequencies orthogonal to those in the 
original image. The anisotropy index was determined by the cell orientation 
distributions extracted from the 2D FFT [61]. The anisotropy index was 
determined by dividing the maximum value of the orientation distribution with the 
expected distribution value at that angle for a perfectly isotropic sample. Three 
random images were taken from each multilayered astrocyte cultures and there 







The height in nanometers of stamped LN patterns was analyzed using a 
commercial AFM (Dimension 3000, Digital Instruments) in the University of Utah 
Microfibrication laboratory using the tapping mode. 
 
2.2.11. Statistical Analysis 
 
All quantitative data were reported as the mean ± standard deviation or as 
a frequency distribution. One way ANOVA was used to compare the means. 
Astrocyte morphological orientation distributions and neurite angle distributions 
were analyzed for differences using a chi square test for independence. The 
relationship between astrocyte and DRG alignment was also assessed using a 
Pearson’s correlation coefficient. Two-tailed student t-test was used to pair-wise 
compare for anisotropy of multilayered astrocyte cultures. p-values < 0.05 were 




2.3.1 Astrocyte Orientation on Printed LN Pattern 
Microcontact printing (Fig. 2-1:A) was used to generate continuous LN 
lanes of 15 m width interspersed with continuous lanes of untreated glass strips 
of 15 m width (Fig. 2-1:C). Clean coverslips stamped with a homogenous LN 
field (Fig. 2-1:B) were used to evaluate the ability of anisotropic LN lanes to direct 
astrocyte orientation. The height of the stamped LN lanes was approximately 5 
nm as measured by AFM using tapping mode (Fig. 2-1:D and E). Primary P1 













Fig. 2-1: Microcontact printing. (A) Casting method for generating patterns of 
extracellular matrix ligand (red) onto the surface of glass coverslips. (B) 
Representative fluorescent image of stamped homogeneous laminin (LN) field 
(green). (C) Representative fluorescent image of micropatterned LN lane pattern 
consisting of alternating 15 μm wide LN lanes (green) and 15 μm wide lanes of 
the unpatterned glass coverslip surface (black). (D and E) Representative atomic 
force microscopy (AFM) image of the topography of a printed LN lane pattern on 
the glass coverslip. The light color plateaus represent the printed LN lanes and 
the darker color represents the bare glass coverslip surface. The step height 
between the printed LN lanes and bare coverslip surface is approximately 5 nm 








that followed the underlying LN lanes 6 hrs after plating and the oriented 
morphology was maintained throughout the whole culture period (Fig. 2-2:G, H 
and I). Astrocytes cultured on the homogenous LN fields had no preferred 
directional orientation (Fig. 2-2:A, B and C). A second cytoskeletal marker, actin, 
was used to confirm the orientation of astrocytes cultured on either isotropic LN 
fields or anisotropic LN lane pattern. When seeded on LN lanes, the orientation 
of actin microfilaments was closely associated with the observed morphological 
orientation of the cells (Fig. 2-2:J, K and L). No preferred orientation of actin was 
observed on isotropic surfaces (Fig. 2-2:D, E and F). These observations 
demonstrated a haptotactic influence of the anisotropic LN substrate distribution 
on the guidance behavior of astrocytes. Confluent astrocytes (both aligned and 
random) were formed 4 days after initially seeding. 
Astrocyte alignment on both patterned and homogeneous LN field 
(unpatterned) surfaces was quantified. The nuclei of oriented astrocytes 
exhibited elliptical morphology with their long axis oriented parallel to the 
underlying LN lane pattern, whereas equal proportions of astrocyte orientation on 
unpatterned surfaces fell within any particular angle bin, indicating random 
orientation on the homogenous LN field (Fig. 2-2:M). Approximately 81% of the 
cells were aligned within 20° of parallel to the long axis of underlying lane pattern 
(Fig. 2-2:N). The difference between the two groups was significant (Chi Square 
Test for Independence, p<0.05). The data demonstrated that nanometer level 
guidance cues can influence the morphology and directional bias of astrocytes 







Fig.2-2: Representative astrocyte orientation behavior on homogeneous and 
patterned LN surfaces stamped on glass coverslips. On homogenous LN fields, 
astrocytes showed nopreferred orientation at 6 h (A), 1 day (B) and 4 days (C) as 
visualized with the indirect immunofluorescent histochemistry (IHC) against the 
intermediate filament Glial Fibrillary Acidic Protein (GFAP) (red), or using 
fluorescently labeled phalloidin to visualize actin microfilament orientation (D-F). 
In sharp contrast, the orientation of GFAP (G-I) and fluorescently labeled actin (J-











Fig.2-2 continued: A quantitative analysis of astrocyte alignment on 
homogeneous stamped LN surfaces (M) showed no preferred directionality, 
whereas a strong bias in the direction of astrocyte alignment on the stamped LN 
lane patterns (N) was evident. The two groups were significantly different as 






2.3.2 Neurite Outgrowth Directionality 
 
A close association was found between the orientation of overlying DRG 
neurite outgrowth trajectory and the morphological orientation of the underlying 
astrocytes. The direction of neurite outgrowth was generally in a direction parallel 
to the aligned astrocytes (Fig. 2-3:C). In general, when DRGs were put on top of 
random astrocytes (cultured on LN field), no overall preferred orientation of 
neurite outgrowth was found (Fig. 2-3:A). DRGs were also cultured on both fixed 
random and fixed oriented astrocytes cultures to assess whether simply the 
presence and the spatial distribution of nondiffusible factors (e.g., ECM proteins 
and cell surface bound ligands) derived from astrocytes were principally 
responsible for the guidance behavior. Similarly, neurite outgrowth exhibited 
strong alignment on the fixed, oriented astrocytes cultures (Fig. 2-3:D). Again, no 
directional biased neurite outgrowth was found on fixed random astrocytes 
cultures (Fig. 2-3:B). The 3D reconstructed confocal images (flipped around the 
Y-axis of a series z-stack images) demonstrated that although neurites 
penetrated into the astrocyte culture they rarely if ever reached the plane of the 
top of the coverslip, suggesting the observed guided neurite outgrowth was 
purely biological mechanism associated with the orientation of the astrocytes (Fig. 
2-3:E and F). Similar to the orientation distribution pattern of the random 
astrocytes cultures, neurite outgrowth angles were near uniformly distributed on 
both live and fixed random astrocytes cultures (Fig. 2-4:A and B). By contrast, 
approximately 89% of neurite angles on both live and fixed oriented astrocytes 











Fig.2-3: Representative confocal images of DRG outgrowth on astrocyte 
monolayers grown on stamped homogeneous LN fields (left panels) or patterned 
LN lanes (right panels). (A) Representative DRG outgrowth (red) on live 
astrocyte monolayers grown on homogeneous LN substrates (GFAP-green) 
showed no overall preferred directional outgrowth. (B) Similarly, no directionally 
biased DRG outgrowth was observed on fixed astrocytes cultures grown on 
homogeneous LN substrates. (C) In sharp contrast, DRG outgrowth on aligned 
astrocytes monolayers grown on patterned LN substrates extended in the 
direction of the underlying astrocytes whether alive (C) or fixed (D). 
Representative, 3D reconstructed confocal images of DRG outgrowth on 
unaligned astrocytes (E, grown on homogeneous stamped LN) or on aligned 
astrocyte monolayers (F) demonstrated that DRG outgrowth rarely penetrated 
into underlying astrocytes and did not reach the surfaces of the stamped 
coverslips showing that all DRG outgrowth was determined by the interaction 
with the astrocytes cell layers. Scale bar= 100 m. Astrocytes were visualized 
with IHC against GFAP (green) while DRG outgrowth was visualized with 












































Fig. 2-4: Quantitative analysis of DRG outgrowth direction on astrocyte 
monolayers grown on stamped homogeneous (left panels) or patterned LN 
surfaces (right panels). The distribution of DRG outgrowth orientation on live (A) 
and on fixed astrocytes monolayers (B) cultured on homogeneous LN substrates 









Fig.2-4 continued: In sharp contrast, DRG outgrowth on live (C) or fixed (D) 
astrocytes grown on patterned LN surfaces showed a strong bias in the direction 
of the orientation of the underlying astrocytes with a high proportion of neurites 
growing within 20o parallel to the direction of the orientation of the underlying 
astrocyte monolayer. The DRG outgrowth direction distribution on astrocyte 
monolayers grown on patterned surfaces (both live and fixed) was significantly 
different from those grown on astrocyte monolayers cultured on stamped 
homogeneous LN fields (both live and fixed) (Chi Square Test for Independence, 





angle distribution was significantly different between random and oriented 
astrocyte groups (Chi Square Test for Independence, p<0.05). Overall, the 
relationship between the orientation of astrocytes and that of neurite outgrowth 
exhibited a strong correlation (Pearson’s correlation coefficient  0.87). 
 
2.3.3 Oriented Astrocytes Direct Outgrowth of Neurites 
 
In an attempt to determine the relationship between neurite trajectory and 
outgrowth length, the directed outgrowth of neurites parallel to the long axis of LN 
lanes (both live and fixed) and that of neurites parallel to a designated axis on 
random astrocytes (both live and fixed) was calculated. DRG outgrowth on 
oriented astrocytes resulted in greater directed outgrowth where 370% and 280%  
increase of directed length were seen on live and fixed oriented astrocytes, 
respectively, than that on fixed random astrocytes, respectively. When compared 
to live random astrocytes, the increase of directed outgrowth dropped to 250% 
and 190%, respectively (Fig. 2-5:A). There was a significant difference in the 
directed length comparison between any two conditions (fixed random, live 
random, fixed oriented and live oriented, one-way ANOVA, p<0.05). The 
distribution of directed neurite length on four conditions was evaluated and it was 
found the maximum value of directed neurite length increased gradually from 
fixed randomly organized, live randomly organized, fixed oriented to live oriented 
astrocytes (Fig. 2-5:B). These results indicated that the alignment as well as the 



















Fig.2-5: Directed neurite outgrowth and directed outgrowth length distributions. 
(A) DRG outgrowth on oriented astrocytes resulted in greater length in a 
particular direction (directed outgrowth) where we observed a 370% and 280% 
increase of the directed length on live and fixed oriented astrocytes monolayers, 
respectively, compared to that observed on fixed random astrocytes, respectively. 
When compared to outgrowth on live random astrocytes, the increase of directed 






















Fig. 2-5 continued: (B) A comparison of the distribution of directed DRG 
outgrowth lengths under the four conditions showed that the DRG outgrowth was 
consistently longer in a larger proportion of the population when the astrocytes 














2.3.4 ECM Expression of Astrocytes and Neurite Outgrowth 
 
Immunofluorescent staining with antisera against astrocyte associated FN, 
CSPG, LN and NCAM all revealed a spatial arrangement parallel to the long axis 
of LN lanes at a certain degree on the oriented astrocyte monolayers (Fig. 2-6:B, 
D, F, and H). The parallel spatial distribution was the most evident with FN, which 
formed fibrillar bundles and was closely associated with the underlying stamped 
LN pattern (Fig. 2-6:B, colocalization data of FN and LN lanes not shown). 
Similarly, the CSPG expression pattern also delineated the underlying printed LN 
lane pattern; however, it was not as distinct as FN and no fibrillar structure of 
CSPG was seen (Fig. 2-6:D). NCAM is a cell membrane associated adhesion 
molecule expressed on astrocyte surface and its expression pattern seemed to 
outline the astrocytes cell membrane (Fig. 2-6:F).  
Although the general pattern of NCAM on aligned astrocytes appeared to 
follow the long axis of printed LN lanes, we did not see similar fibrillar structure to 
what we observed for FN. In order to investigate the distribution pattern of 
astrocytes derived LN, FN lanes (400 g/ml, Invitrogen) was patterned on the 
underlying substrate. The anisotropic nature of oriented astrocytes derived LN 
was the least obvious. (Fig. 2.6H). The spatial pattern of immunostaining of all 
four extracellular matrix molecules on random astrocytes revealed no preferred 
orientation (Fig. 2-6:A, C, E and G). Although the overall pattern of FN on 
random astrocytes was not organized, small patches appeared organized where 
we observed that neurite outgrowth followed these oriented ligands (Fig. 2-6:A 





Fig. 2-6: Spatial distribution of extracellular matrix molecules expressed by 
astrocytes and their association with DRG outgrowth on homogeneous LN 
substrates (left panels) and (patterned LN substrates (right panels). Astrocyte 
derived FN had a fibrillar structure when grown on homogeneous LN substrates 
(A) and patterned LN lanes (B). Neurite outgrowth was found to be closely 
associated with astrocytes derived FN. Although the overall pattern of FN 
expressed by astrocytes grown on homogeneous LN substrates was not 
organized, neurite outgrowth tended to follow locally oriented FN fibers (see 
arrow in panel A). CSPG expression appeared as punctuate expression pattern 
that was unorganized on the homogeneous LN substrates astrocytes (C) and on 
aligned astrocytes, as seen with FN (B), appeared to co-align with the underlying 
pattern of the stamped LN lanes (D). Neurites were found to extend through 
areas with both high and low expression of CSPG in both culture conditions. The 
expression of NCAM by both random (E) and aligned astrocyte (F) seemed to 
delineate astrocyte membranes and act as permissive substrates for neurite to 
grow. Astrocyte derived LN had similar punctate expression pattern as CSPG on 
both random (G) and aligned (H) culture and acted as supportive substrates for 
neurite outgrowth. FN was in green in (A, B); CSPG was in green in (C, D); 
NCAM was in green in (E, F) and LN was in green in (G, H). Neurites were in red 





















by the CSPG distribution and the neurites were found to extend through areas of 
both high and low levels of CSPG expression (Fig. 2-6:D). This phenomenon was 
also seen with neurites grown on random astrocytes cultures (Fig. 2-6:C), 
suggesting CSPG derived from astrocytes in our culture conditions might have a 
weak inhibitory effect on neurite outgrowth that could be overwhelmed by other 
permissive guidance cues. The expression patterns of randomly organized 
astrocytes derived NCAM and LN showed no preferred directionality (Fig. 2-6:E 
and G). The fact that neurites were found to be following with linear arrays of FN 
expressed on the oriented astrocytes as well as on the random astrocytes when 
these bundles oriented locally suggested a principal role of astrocyte derived FN 
in guiding neuronal pathfinding 
 
2.3.5 FN as Guiding Ligand 
 
Among all astrocyte derived insoluble ligands investigated, the anisotropic 
nature of FN suggests it might act as the most distinct path guiding ligand as 
revealed by indirect immunohistochemical reactions. Thus, we decided to 
examine what role that FN plays in interactions with DRG neurite outgrowth. 
DRG neurons were cultured on fixed oriented astrocyte cultures with or without 
anti-FN antisera treatment. There were more than 82% of neurites oriented within 
20° of the long axis of the underlying LN lanes on untreated fixed oriented 
astrocyte monolayers (Fig. 2-7:A), whereas following anti-FN antisera treatment, 
the number of neurites oriented within 20° dropped to 46% (Fig. 2-7:B). There 
was a statistical difference between untreated and treated groups (Chi Square  









Fig. 2-7: Antibodies to astrocyte derived FN attenuated the directed outgrowth of 
DRGs on aligned astrocytes monolayers. (A) More than 80% of DRG neurite 
outgrowth on untreated, fixed oriented astrocyte monolayers was observed 
growing within 20o of the long axis of the orientation of the underlying stamped 
LN lanes. (B) Following anti-FN antisera treatment, the percentage of neurites 
within 20o dropped to 46% that was significantly different using the Chi Square 








is a potent guiding ligand for DRG neuronal pathfinding. 
 
2.3.6 Surface Cues Influence Tissue Organization 
 
Following the first astrocyte layer reached confluence on either 
isotropically (LN field) or anisotropically patterned surface (LN lane pattern), 
additional astrocyte seedings were applied on top of the first layer and so on to 
investigate if the first aligned astrocyte monolayer was capable of transmitting the 
directional cues to subsequent cell layers and manipulate the organization of the 
overlying cell layer organization. Astrocyte derived FN was used as an indicator 
for cellular orientation as it was shown that the anisotropy of FN on aligned 
astrocyte monolayers was most conspicuous parallel to astrocyte alignment (Fig. 
2-6:B). Both random and aligned, multilayered astrocyte cultures were 
mechanically separated from the coverslips using forceps. No preferred spatial 
organization of FN of randomly organized, multilayered astrocyte cultures was 
observed (Fig. 2-8:A). On the contrary, the cellular alignment was preserved 
when astrocytes were repeatedly seeded on the aligned astrocyte monolayers 
(Fig. 2-8:B). The orientation distribution of FN within the randomly organized, 
multilayered astrocytes maintained unbiased (Fig. 2-8:C) whereas the FN 
distribution of aligned, multilayered astrocytes peaked around 90° (Fig. 2-8:D, 
parallel to the printed LN lanes). The anisotropy index further demonstrated the 
preserved anisotropy of the aligned, multilayered astrocyte cultures (Fig. 2-8:E). 
DAPI staining showed the multilayered structure of astrocyte cultures following 
multiple seedings (Fig. 2-8:F). Reconstructed 3D confocal images also confirmed 

























Fig.2-8: The orientation of stamped LN is transferred through multiple cell layers 
to determine the overall organization of a multilayered astrocyte cell construct. 
Representative low magnification confocal stacked fluorescent images showing 
the spatial distribution of FN expressed within a multilayered astrocyte construct 
gown on a homogeneously stamped LN substrate (A) and on a patterned LN 









Fig. 2-8 continued: A 2D FFT analysis on both z-stack confocal images showed 
that FN orientation distribution on the randomly organized, multilayered astrocyte 
cultures remained unbiased (C) whereas FN distribution on the aligned, 
multilayered astrocyte cell constructs peaked around 90o, parallel to the long axis 








Fig. 2-8 continued:(E) An anisotropy index showed that cellular alignment was 
maintained within the aligned multilayered, astrocyte cell construct (Two-Tailed 
Student t-Test p < 0.05). (F) Representative cross-sectional view of the DAPI 
stained astrocyte nuclei showing the thickness of the cell construct. (G) 
Representative 3D reconstructed confocal image showing that the spatial 
distribution of FN remained aligned throughout the thickness of the astrocyte cell 
construct grown on a stamped LN substrate. FN was visualized with IHC and is 






multilayered astrocyte structure (Fig. 2-8:G). This result demonstrated that 
surface guidance cues can be transmitted to overlying cell layers via the 
directional information carried by the spatial distribution of ligands present on an 




Findings of this study demonstrated that the alignment of cultured 
astrocytes can be controlled by the anisotropic orientation of biomaterial surface 
ligands that are only a few nanometers in height. Further, spatially oriented 
astrocytes are capable of directing neuronal outgrowth from their apical surfaces, 
as well as controlling the orientation of multiple astrocyte cell layers that are 
orders of magnitude larger than the initial templating ligands. This approach 
provides an opportunity to investigate the molecular mechanism by which 
astrocytes guide neuronal pathfinding in the absence of other interfering cues, 
such as topographical undulations as introduced by grooved guidance substrates 
[25, 26, 29]. 
We also demonstrated that the spatial organization of astrocyte derived 
insoluble factors is sufficient to direct neurite outgrowth grown on featureless 
surfaces showing that purely biological mechanisms are sufficient to guide tissue 
level organization. Our immunohistochemical analysis further suggested the 
involvement of linear arrays of astrocyte associated FN as a principal 
organizational mechanism. Together, these in vitro studies suggest an approach 
to create a multilayered-tissue construct with oriented morphology that could be 





Astrocytes, as a major glial cell type in the CNS, have been recognized as 
supportive substrates for neuronal growth through the secretion of diffusible 
neurotrophic factors and the expression of such insoluble permissive factors as 
ECM proteins, cell adhesion and cell surface ligands [11, 12, 14, 33]. Studies 
have demonstrated that axons tend to follow the orientation of surrounding 
astroglial cells [7-11] and suggest that the formation of glial cell based tracts or 
boundaries precedes and guides neuronal pathfinding during CNS development 
[1-7, 17-19]. 
However, following CNS injury, along with upregulation of a variety of 
inhibitory molecules [34-38, 60,] the disrupted extracellular milieu is accompanied 
by the formation of a disorganized glial scar that is also recognized as a major 
impediment to axonal regeneration [20-22]. Recently, the beneficial roles of 
reactive astrocytes after CNS injury have been revealed where they are involved 
in functional recovery and modulation of inflammatory cells [39]. Therefore, 
strategies that maintain such positive contributions of reactive astrocytes while 
also providing directional information to constrain axonal regeneration trajectory 
may be useful clinically. 
In our studies, the alignment of astrocytes was achieved by patterning 
nanometer level LN molecules as surface guidance cues on otherwise planar 
substrates. Patterned substrates have been shown to control cell orientation and 
function [40, 41] and ECM proteins patterned in different shapes can affect the 
polarization of cell internal organization and future cell division axis [42, 43]. The 





interaction between the chemisorbed LN lanes and such ECM receptors as 
dystroglycan (DG) and integrin 1 that are found on astrocytes. Each of these 
receptors has been shown to regulate astrocyte attachment and actin 
organization in response to LN [44, 45]. 
Previously several groups have shown that aligned astrocytes can direct 
neurite outgrowth. These approaches used grooved substrate topography on the 
order of hundreds of nanometers to hundreds of microns [25, 26, 29]. Thus, in 
these studies it is unclear whether neurite outgrowth was affected by the surface 
undulations of the grooved substrates [30]. Previously, we reported that when the 
R.M.S roughness of the substrate is below 45 nm, grooved substrates failed to 
direct astrocyte orientation [25]. Therefore, the observed alignment of astrocytes 
on planar surfaces printed with nanometer-level surface cues (5 nm) indicates 
that the biological aspect of astrocyte orientation alone is sufficient to direct 
oriented neurite outgrowth in the absence of mechanical cues that could 
influence neurite trajectories via a different mechanism. 
In this study, neurites were found to follow the alignment of underlying 
astrocytes (live and fixed), indicating that nanometer level surface cues on a 
planar bridging substrate are sufficient to affect the directional outgrowth of 
adjacent neural tissue through an intervening astrocyte layer. The 
astrocyte/meningeal cell interface is thought to be a barrier to axonal 
regeneration due to the fact that axons tend to stay on top of astrocytes and are 
unwilling to across the boundary [46]. However, it has been shown that oriented 





Therefore it would be interesting to see whether such a regeneration barrier 
could be overcome by inducing organization to these two major cellular 
components of the glial scar. 
The length of directed neurite outgrowth was found to be a function of both 
the viability and orientation of underlying astrocytes since DRG neurites grown 
on fixed astrocyte monolayers lack of the neurotrophic factors released from 
astrocytes [33] and glial cell alignment has been shown to enhance directed 
neurite outgrowth [24, 25, 28]. This result suggests that a simple approach with 
organized, nanometer level surface cues on a CNS implanted bridging device 
may be used to organize the reactive astrocyte layer that encapsulates the 
implant, and could be used to affect the trajectory of regenerating axons at the 
device surface. 
The fact that neurites still grow parallel on fixed oriented astrocytes 
demonstrated that the spatial distribution of ECM proteins and/or cell surface 
bound ligands derived from astrocytes are sufficient to guide neurite extension. It 
was proposed by Tessier-Lavigne and colleagues that ECM proteins act as short 
range cues to guide growth cone extension [48] and a great number of ECM 
proteins and/or surface bound ligands have been demonstrated to affect neurite 
outgrowth trajectory [11, 12, 14, 18, 19, 49-51]. 
Permissive and/or repulsive ligands immobilized on culture substrates in 
different geometries effectively guide outgrowth [50, 52-54]. Therefore, one 
potential molecular mechanism by which oriented astrocytes govern the 





and/or surface bound ligands that mediate neuron–astrocyte interaction and 
provide directional information. DRG neurites grown on astrocytes aligned on a 
planar surface provide an opportunity to investigate the molecular mechanism 
without the interference of other physical guidance mechanisms. Our results 
suggest that one could engineer artificial bridging devices through mimicking the 
spatial arrangement of these insoluble ligands displayed on oriented astrocytes. 
DRG neurites were found making direct contact and closely associated 
with the continuous array of astrocyte derived FN, suggesting the potential role of 
FN in guiding neurite outgrowth. This close association between neurites and 
astrocyte associated FN was also observed previously where DRGs were grown 
on astrocytes aligned by grooved substrates [25]. In the present study, the direct 
role of astrocyte associated FN in guiding neurite outgrowth was strengthened 
due to the fact that no other mechanical guidance cues were contributing to the 
alignment of neurites. 
Indeed, FN has been demonstrated to be critical for sensory axonal 
regeneration in adult rat corpus callosum [11] and to modulate neurite outgrowth 
[50]. However, DRG neurites were found not always making direct contact with 
astrocyte associated FN. We speculate that after receiving guidance information, 
neurites might be able to maintain outgrowth trajectory for a certain amount of 
time or distance traveled before they acquire new information due to the intrinsic 
stiffness of the trailing axon [31]. Therefore, while not always making direct 
contact with FN, neurites maintained parallel outgrowth. Still, this observation 







guiding neurite extension, such as NCAM [14]. However, the fact that the 
majority of neurites were not able to maintain directional outgrowth following anti-
FN antisera treatment did demonstrate that astrocyte derived FN is a potent 
mechanism for guiding neurite outgrowth. 
The observation that neurite growth was not affected by the level of CSPG 
expression can be explained in many ways. For example, the different sulfation 
pattern of glycosaminoglycan (GAG) chains has been shown to render CSPG 
distinct properties, either permissive or inhibitory [55, 56]. The other possibility is 
that in our culture system the CSPG exerted inhibitory signals were overridden 
by other astrocyte derived permissive molecules [36]. The spatial distribution of 
astrocytes derived NCAM and LN did not appear to exhibit the same 
conspicuous anisotropic orientation as observed for FN. Their expression pattern 
suggested that they might be directing neurite outgrowth in a way different than 
FN by providing a permissive substrate that neurites prefer to extend on. 
It has been suggested that cells lose alignment on patterned surfaces 
once the thickness of the cell/tissue layers goes beyond 20–40 m [57]. However, 
in the current study, we demonstrated that the alignment of astrocytes within a 
multilayered structure can be maintained for at least 30 m in thickness in a fixed 
specimen, which under hydrated conditions is likely much thicker. It will be 
interesting to see if this behavior is cell type specific. It also will be interesting to 
investigate how thick of the multilayered structure could become in which 





While many studies have demonstrated the repulsive nature of various 
scar-associated ligands in inhibiting axonal regeneration [34, 58, 59], very few 
studies have suggested how scar tissue may develop. In the current study, we 
demonstrate that astrocyte alignment can be transmitted through multiple cell 
layers to control the organization of a tissue construct, potentially via the 
directional cues carried by a network of spatially organized, astrocyte associated 
cell surface receptors and ECM ligands. Likewise our data suggest that 
disorganized astrocytes likely transmit their lack of organization, which likely 
contributes to the development of the dense inhibitory scar tissue that inhibits 




Our studies performed totally in vitro show that the manner in which 
biomaterial bound surface ligands are presented affects the spatial organization 
of a population of cells at a biomaterial surface. Moreover, such organized 
patterns of surface ligands can strongly influence the directional outgrowth of 
neurons interacting with the surface of an organized astrocyte cell layer, as well 
as being transmitted through multiple cell layers to control the organization of a 
tissue construct. The results suggest that axonal regeneration can be facilitated 
following injuries if an organized glial framework is provided at a biomaterial 
surface. The results of our in vitro studies also suggest a biological mechanism 
by which a disorganized glial framework can develop into inhibitory scar tissue 
following injury, and conversely how an organized astrocyte framework could be 
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ORIENTED ASTROCYTE BASED BIOMATERIAL CONSTRUCTS FOR  
 





In the spinal cord, longitudinally aligned astrocytes are found to arrange 
their processes along the fiber tracts parallel to the trajectories of nerve fibers [1-
4]. Following spinal cord injury (SCI), this oriented glial cell framework is 
interrupted at the injury site accompanied by the formation of disorganized glial 
scar tissues and accumulation of various scar associated inhibitory ligands [5-9]. 
While many researchers have been investigating strategies to mitigate the 
repulsive effects of these inhibitory molecules to facilitate axonal regeneration 
[10-12], very few have looked at how much the inhibitory nature of the glial scar 
is contributed by its disorganized cellular structure and ligand distribution. 
Cell transplantation studies have suggested the positive correlation 
between the organized astrocyte framework and efficacy of axonal regeneration 
following SCI [4, 6, 13, 14]. Transplanted DRG neurons have been found to send 
out lengthy axonal processes along injured white matter tracts of adult rats, being 
closely associated with aligned host astrocytic processes [4, 6]. In addition, 
astrocytes derived from glial restricted precursors have been shown to guide and 







Forming reactive astrocyte processes toward the lesion center [13,14]. Similar 
rearrangement of host glial cells, which then guide trajectories of regenerating 
sensory fibers across the injured dorsal root entry zone has also been 
documented following olfactory ensheathing cell (OEC) transplantation [15,16]. 
Unlike mammalian animals whose central nervous system (CNS) axons 
regenerate following injury but only to a limited extent, the regenerating CNS 
axons of nonmammalian vertebrates can penetrate through the glial scar [17-19]. 
The ability of the neuroepithelial cells residing in the nonmammalian vertebrate 
spinal cord to reform the organized pathway following injury has been suggested 
to be at least partially attributed to the observed successful axonal regeneration.  
These observations lead to the hypothesis that reconstructing an 
organized glial cell framework at the injury site following SCI could be beneficial 
for axonal regeneration. 
It has been demonstrated that alignment of astrocyte monolayers can be 
manipulated by various approaches in vitro, including physical surface undulation 
[20-23] and external electric field [24]. In particular, our lab used nanometer-level 
surface cues to induce astrocyte monolayer organization [55]. We have further 
shown that organizational cues provided by the first oriented astrocyte monolayer 
can be transmitted through several overlying astrocyte cell layers to induce 
orientation of the entire construct morphologically and with regard to its secreted 
matrix proteins, suggesting the possibility of using such structure to induce glial 









have been successfully engineered in these 2D culture systems, it is unclear 
whether such organized structure could be transferred for in vivo applications. 
The aim of the present study was to build on our previous work and 
develop implantable, organized astrocyte constructs in vitro, such that its 
therapeutic potential for SCI repair could be evaluated in vivo. Indirect 
immunohistochemical reactions were applied to investigate the cellular 
orientation as well as the spatial organization of matrix proteins within recovered 
astrocyte constructs. DRG outgrowth assay was then used to evaluate the ability 
of astrocyte constructs to guide axonal regeneration in vitro. The feasibility of 
recovered astrocyte constructs to be manipulated into different geometries for 
implantation to different injury sites was examined. The possibility of harvesting 
oriented astrocyte derived acellular ECM constructs was also explored. Last, the 
ability of acellular, oriented astrocyte derived ECM constructs to support and 
guide DRG outgrowth was tested in vitro. 
                                                        
3.2. Materials and Methods 
 
3.2.1 Micropatterning Device Fabrication 
 
Microcontact printing devices were designed and fabricated as previously 
described [55]. Briefly, polydimethylsiloxane (PDMS, R-2615, Nusil) microcontact 
printing devices were designed using L-Edit software and fabricated in the 
University of Utah Microfibrication laboratory. PDMS two component kit was 
mixed in a 1:10 ratio, vacuumed treated to remove bubbles, poured into a mold 
and then cured for 30 mins at 100oC. The cured PDMS stamps were peeled off 







with the isotropic pattern were designed to have flat surfaces whereas stamps 
with the anisotropic pattern were designed to have continuous lanes (15 m wide) 
interspersed with continuous grooves (15 m wide). 
 
3.2.2 Microcontact Printing 
 
Round glass coverslips (18mm diameter) were cleaned by rinsing with 
acetone, isopropanol followed by double distilled deionized (DD) water, then 
sonicated for 20 mins and autoclaved. Nine l laminin (LN, 400 g/ml, Sigma) 
was applied to PDMS printing devices and coverslipped to spread protein 
solution over the entire device surface for 25 mins. After adsorption, stamps were 
rinsed with sterile DD water and briefly dried under a nitrogen stream. LN 
adsorbed stamps with either flat surface or alternating 15 m wide lanes and 
grooves were brought into contact with clean coverslips and then removed.  
 
3.2.3 Astrocyte and DRG Isolation and Preparation  
 
Purified primary rat neonatal cortical astrocytes were isolated as 
previously described [48]. Briefly, cerebral cortices of postnatal Day 1 (P1) 
Sprague-Dawley rats were dissected with meninges removed. Dissected rat 
cortical tissue was minced and digested (1.33% collagenase, 30 mins, 
Worthington Biochemical) followed by 0.25% trypsin treatment (30 mins, 
Worthington Biochemical). The cells were then triturated and suspended in 
DMEM/F12 medium (Invitrogen) with 10% fetal bovine serum (FBS, Sigma). 
Dissected cells were plated in 75 cm2 flasks. After 1 week, purified astrocytes 





Dorsal root ganglion neurons (DRG) were isolated from P1 rats as 
previously described [21]. Ganglion neurons were dissected out from both sides 
of the spinal column. Nerve roots and attached connective tissue were removed 
and the ganglia neurons were trypsin/collagenase treated (0.25%/0.33%) for 30 
mins. Digested DRGs were triturated and the resulting cell suspension was 
centrifuged and placed in 1 ml DMEM/F12 plus 50 μl of DNase. Isolated DRG 
neurons were washed by centrifugation, and ready for seeding. 
 
3.2.4 Engineering 3D Astrocyte Constructs and DRG Culture 
  
Purified rat cortical astrocytes were seeded on patterned (anisotropic) and 
unpatterned (isotropic) surfaces at a density of 52,000 cells/cm2 with serum free 
medium (SATO-) over the first 4-6 hrs and then switched to 10% FBS 
supplemented with 50 μg/ml ascorbic acid (Sigma) and 150 μg/ml ascorbate-2-
phosphate (Sigma) for 2 days to create the first confluent, oriented and randomly 
organized astrocyte monolayers, respectively. Ascorbic acid and ascorbate 
supplementation has been shown to increase cell ECM production [30]. Then, 
subsequent seeding was applied on the previous confluent cell layers at the 
same density every other day for multiple times. Half of the culture medium in 
each well was replaced with fresh medium the day following cell seeding starting 
the 3rd cell seeding process. After 10-14 days of culture, hydrophilic membranes 
(CellSeed) were put atop the apical surface of dense astrocyte constructs and 
astrocyte constructs were harvested from the coverslips by peeling off the 
membranes with forceps. Excess culture medium was used to separate the 





with 4% paraformaldehyde for 15 mins. Prior DRG neuron seeding, fixed 
astrocyte constructs were rinsed with sterile PBS several times. 
Dissociated DRG neurons were seeded at 1500 neurons/50 μl 10% FBS 
supplemented with 10 ng/ml NGF (Sigma) per fixed astrocyte construct and let sit 
for 1 hr to attach. Then, the culture medium supplemented with NGF (10 ng/ml) 
was added. DRG neurons were cultured for 2 days and then fixed with 4% 
paraformaldehyde. 
 
3.2.5 Decellularization of Oriented Astrocyte Constructs  
 
and DRG Culture 
 
Recovered oriented astrocyte constructs with attached membranes were 
placed in hypotonic Tris-HCl buffer (10 mM, pH 8.0) containing 0.1% EDTA and 
10 KIU/ml aprotinin (Sigma) for 1-2 hrs at room temperature (R.T.) to weaken 
integrin-ECM interactions and deactivate released proteases due to cell body 
rupture. Hydrophilic membranes were then removed and oriented constructs 
were immersed in 0.1% sodium dodecyl sulfate (SDS,10 mM Tris-HCl, pH 8.0) 
on a rocker at 100 rpm at R.T. overnight to solubilize lipid membranes. Following 
detergent treatment, oriented constructs were rinsed three times, 30 mins each, 
in sterile PBS on a rocker. Last, oriented constructs were treated with Tri-HCl 
buffer (50 mM, pH 7.5) containing RNase (1 U/ml, Sigma) and DNase (50 U/ml, 
Sigma) on a rocker at 37oC for 3 hrs, followed by rinsing with sterile PBS three 
times, 30 mins each, on a rocker.  
Acellular, oriented astrocyte derived ECM constructs were first air-dried in 





Dissociated DRG neurons were cultured on the acellular ECM constructs at a 
density of 1500 neurons/50 μl 10% FBS supplemented with 10 ng/ml NGF. DRG 
neurons were seeded and let sit for 1hr to attach. Then, the rest of the 10% FBS 
supplemented with NGF (10 ng/ml) was added. DRG neurons were cultured for 2 
days and then fixed with 4% paraformaldehyde. 
 




To engineer multistacked, astrocyte constructs, the first harvested 
astrocyte construct was put atop the second astrocyte construct and incubated 
for 20 mins with 50-100 μl of culture medium added atop the hydrophilic 
membrane to keep constructs hydrated. The double-stacked constructs were 
harvested by gently peeling off the membrane with forceps and then separated 
from the membrane by adding excess culture medium. After being released from 
the membranes, double-stacked constructs were fixed with 4% 
paraformaldehyde for 15 mins.  
Agar powder (Gibco) was dissolved into warm D.I. water to make a final 
concentration of 2.5% agar solution. Agar solution was injected into a laboratory 
tubing (Dow Corning) of 0.51 mm inner diameter and let cool down to solidify. A 
syringe was used to push out the solidified agar rod from the plastic tubing. An 
astrocyte construct was wrapped around an agar rod using forceps under a 
dissecting microscope to make a tubular astrocyte construct and then incubated 
for another 30 mins. The cylindrical astrocyte construct was then fixed with 4% 





Recovered astrocyte constructs were wrapped around laboratory tubings 
(Dow Corning) with hand hold forceps and cultured for another week in culture 
medium supplemented with ascorbic acid (50 μg/ml) and ascorbate-2-phosphate 
(150 μg/ml). After 1 week, self-supporting astrocyte tubes with open lumens were 
removed from plastic tubings, fixed with 4% paraformaldehyde for 30 mins then 
followed by lyophilization. Acellular astrocyte ECM tubes were prepared by 
decellularizing self-supporting astrocyte tubes with plastic tubings attached 
following the procedures described in section 2.5. After lyophilization, plastic 
tubing was removed from the acellular astrocyte ECM tube. 
 
3.2.7 Cryostat Sectioning  
 
Agar powder (Gibco) was dissolved into warm D.I. water to make a final 
concentration of 0.8% agar solution. Single, double-stacked astrocyte constructs 
and tubular astrocyte constructs were placed in a square mold and warm 0.8% 
agar solution was slowly poured into the mold to cover the samples and let them 
cool down. Solidified 0.8% agar cubes with embedded samples were removed 
from the mold and left in 30% sucrose solution overnight. Agar cubes were then 
put on cryostat specimen holders in the desired orientation. Tissue freezing 
medium (Triangle Biomedical Science) was added to cover the agar cubes and 
the specimens were then placed in the cryostat at -20oC. Specimens were cut 










3.2.8 Immunohistochemical Staining 
 
For intracellular antigens, fixed samples were treated with 0.05% Triton X-
100 in PBS for 15 mins and rinsed with PBS. No Triton was applied for the 
extracellular matrix molecular immunohistochemical detection. When intracellular 
ligands were co-stained with extracellular ligands, extracellular ligands were 
always processed first, followed by Triton treatment and immunohistochemical 
reactions for intracellular ligands. Prior indirect immunohistochemical reactions, 
cryostat sections were rinsed with PBS to remove tissue freezing medium. 
Samples were blocked with 4% goat serum and 0.1% sodium azide in PBS for 1 
hr and incubated with primary antisera against glial fibrillary acidic protein (GFAP, 
DAKO, 1:1000), neurofilament 160 (NF-160, Sigma, 1:500), laminin (LN, Sigma, 
1:500), cellular fibronectin (FN, Sigma, 1:500), chondroitin sulfate proteoglycan 
(CS-56, Sigma, 1:500), Neural cell adhesion molecule (NCAM, Sigma, 1:500) 
and Type-1 collagen (Coll, Sigma, 1:500). Fluorescent dye conjugated secondary 
antibodies (Molecular Probes) were applied at dilution of 1:500 except for GFAP 
(1:1000). All antibodies were diluted in 4% goat serum and 0.1% azide and 
applied for 24 hrs at room temperature. Three washes with 30 mins each were 
applied between applications of primary and secondary antisera. DAPI (10 μM; 
Molecular Probes) was used for all cell nuclei visualization. Tissue sections were 
mounted on microscope slides covered with Fluormount-G (Southern Biotech), 
and coverslipped. Images were acquired using a Nikon epifluorescence 
microscope equipped with a CCD camera (ImagePro, Media Cybernetics) or 







3.3.1 Engineering 3D Astrocyte Constructs 
 
To engineer 3D astrocyte constructs with either unorganized or organized 
cellular orientation, micropatterning was used to transfer isotropic (LN field) or 
anisotropic (LN lanes) protein patterns to glass coverslips as previously 
described [55]. The LN field stamped surface and LN lanes patterned surface will 
be referred to as unpatterned and patterned surfaces, respectively, throughout 
the manuscript. The 3D astrocyte construct culturing and harvesting procedure is 
schematically illustrated in Figure. 3-1. Primary rat cortical astrocytes were 
seeded on top of both unpatterned and patterned surfaces in SATO- medium 
over the first 4-6 hrs to facilitate attachment and then switched to 10% FBS 
supplemented with ascorbic acid and ascorbate. In 2 days, the first astrocyte 
layer was observed to reach confluence on both surfaces. The seeding process 
was then repeated every other day with the same cell density. The elongated 
morphology of subsequent astrocyte layers cultured on the first oriented 
astrocyte monolayer induced by the patterned surface was preserved throughout 
the culture period via microscopic bright field observation. This alignment was not 
observed for astrocytes cultured on unpatterned surfaces.  
After 5-7 seedings, a dense astrocyte construct was formed atop the 
coverslip and ready to be harvested with a hydrophilic membrane. The recovered 
construct was then separated from the membrane by adding excess medium to 
the composite. The hydrophilic membranes prevented shrinkage of recovered 































































































































































































































































































































































































shrank about 50% isotropically without the application of membranes, whereas 
constructs recovered from the patterned surfaces shrank anisotropically more in 
the direction parallel to the long axis of printed LN lanes (data not shown). 
Harvested astrocyte constructs were mechanically stable floating in the medium 
(Fig. 3-2:A) and a piece of sheet-like material was obtained following 
lyophilization (Fig. 3-2:B). 
 
3.3.2 Characterization of Engineered Astrocyte Constructs 
 
Astrocyte constructs were cryostat-sectioned transversely. The 
multilayered structure within the constructs was clearly seen with the DAPI+ 
astrocyte nuclei staining (Fig. 3-3). The thickness of both randomly organized 
 
 
Fig. 3-2 Representative macroscopic image of recovered astrocyte constructs. (A) 
Recovered astrocyte constructs were mechanically stable to float in the medium. 
(B) After lyophilization, astrocyte constructs became a piece of sheet-like 








































Fig. 3-3 Representative cross-sectional images of the recovered, 5 seedings 
astrocyte constructs. The harvested construct was primarily composed of 
astrocytes visualized by the immunofluorescent GFAP staining (A, in red). 
Astrocyte associated ligands, FN (B, in red), NCAM (C, in red), LN (D, in green) 
and CSPG (E, in green), were distributed throughout the entire construct. In 
particular, ascorbic acid and ascorbate treatment resulted in positive type-1 
collagen detection (F, in green). The multilayered structure of the constructs was 









 and oriented constructs was about 30 m after 5 seedings when they were 
dehydrated and mounted, suggesting the thickness of the constructs would 
increase in the hydration state. The cross-sectional views showed that astrocyte 
associated ECMs such as FN, LN, CSPG and a membrane bound ligand NCAM 
were distributed throughout the entire constructs (Fig. 3-3:B, C, D and E). In 
particular, ascorbic acid and ascorbate supplementation resulted in positive type-
1 collagen detection within the astrocyte constructs (Fig. 3-3:F)  
Confocal microscopic images further demonstrated a strong bias of the 
orientation of astrocyte associated ligands. Intracellular cytoskeletal protein 
GFAP and astrocyte derived ECM protein FN also showed anisotropic 
distribution throughout the aligned astrocyte constructs that were recovered from 
patterned coverslip surface/s (Fig. 3-4:B, B1 and B2),whereas unorganized 
distribution of GFAP and FN was seen in randomly organized astrocyte 
constructs harvested from unpatterned surfaces (Fig. 3-4:A, A1 and A2). FN was 
expressed in a fibrillar structure in both culture conditions (Fig. 3-4:A2 and B2). 
Similar to FN, the spatial organization of CSPG also had a biased orientation in 
aligned astrocyte constructs (Fig. 3-4:D and D1). On the other hand, CSPG 
distribution in randomly organized constructs was unbiased (Fig. 3-4:C and C1). 
Astrocyte derived LN also exhibited anisotropy at a certain degree (Fig. 3-4:D 
and D2) in aligned constructs but not in randomly organized constructs (Fig. 3-








Fig. 3-4 Representative z-stacked confocal images demonstrating the spatial 
organization of various astrocyte associated ligands within either randomly 
organized or aligned astrocyte constructs that were engineered by chemisorbed 
ligand patterns. (A) No preferred orientation of astrocyte specific interfilament 
marker, GFAP (A1, in red) and extracellular ligand, FN (A2, in green), was 
observed in randomly organized astrocyte constructs. (B) In sharp contrast, a 
strong bias of the orientation of GFAP (B1, in red) and FN (B2, in green) within 
the entire aligned astrocyte constructs was seen. Astrocyte derived FN appeared 
to have a fibrillar structure in both culture conditions (A2 and B2, in green). (C) 
Similarly, the spatial organization of CSPG (C1, in green) and LN (C2, in red) in 
the randomly organized astrocyte constructs appeared disorganized. Whereas 
spatially organized CSPG (D1, in green) and LN (D2, in red) distributions were 
noticed within the aligned astrocyte constructs. A1 and B1 represent the GFAP 
channel from (A) and (B), respectively. A2 and B2 represent the FN channel from 
(A) and (B), respectively. C1 and D1 represent CSPG channel from (C) and (D), 
respectively. C2 and D2 represent the LN channel from (C) and (D), respectively. 







FN and CSPG. The anisotropic distribution of NCAM and type-1 collagen was 
also only observed in oriented astrocyte constructs (data not shown). 
 
3.3.3 DRG Outgrowth on Engineered Astrocyte Constructs 
 
Isolated primary P1 DRG neurons were seeded on either fixed randomly 
organized or fixed oriented astrocyte constructs, respectively, to investigate their 
ability to support and guide neuronal outgrowth. While DRG neurons were found 
to extend processes on both random and aligned constructs, directed DRG 
neurite outgrowth (i.e., neurite extension in a preferred direction) parallel to the 
spatial organization of astrocyte derived ECM ligands was only observed on fixed 




















Fig. 3-5: Representative DRG outgrowth behavior on engineered aligned 
astrocyte constructs. DRG neurites (in red) were found to extend in a preferred 
direction parallel the spatial organization of oriented astrocyte constructs 
associated ligands, CSPG (in green) and LN (in blue).This directed outgrowth 
behavior is similar to what we observed previously on the 2D astrocyte 





3.3.4 Manipulation of Engineered Astrocyte Constructs 
Both randomly organized and oriented constructs were mechanically 
stable and manipulatable. Immediately after being peeled off from coverslips, one 
construct was stacked atop a second construct and incubated for 20-30 mins at 
37oC to engineer a double-stacked astrocyte construct. DAPI+ astrocyte nuclei 
staining clearly demonstrated that the number of cell layers as well as the 
thickness of a double-stacked construct increased (Fig. 3-6:A and B) when 
compared to a single construct in Figure. 3-3. All astrocyte associated ligands 
investigated (e.g., FN, NCAM) were distributed throughout the double-stacked 
constructs in a way similar to single constructs (Fig. 3-6:A and B). 
Astrocyte constructs were also wrapped around agar rods using hand-hold 
forceps to form tubular astrocyte constructs of length on the level of millimeters 
(Fig. 3-6C). Cross-sections of a cylindrical astrocyte constructs showed that the 
tubular structure around the agar rod was formed by several layers of an 
astrocyte construct, visualized by GFAP and astrocyte derived FN (Fig. 3-6:D). In 
addition, recovered astrocyte constructs were also wrapped around plastic 
tubings and then cultured for another week. After 1 week in culture, the layers of 
the astrocyte construct around the tubings fused and a self-holing astrocyte tube 
with an open lumen was formed following removal of the tubing (Fig. 3-6:E and 
F).  
 
3.3.5 Decellularization of Oriented Astrocyte Constructs 
 
As we found that no ECM materials can be collected when the oriented 












































































































































































































































































































































































































































































































































































































































































































































































































ascorbic acid and ascorbate-2-phosphate were then supplemented in the culture 
medium to boost ECM deposition of astrocytes. Following recovery, oriented 
astrocyte constructs were decellularized to remove cellular components and 
nuclear materials. Confocal microscopic images demonstrated that the 
decellularization process was effective such that little to no immuofluorescent 
signals of intracellular components and nuclear materials (Fig. 3-7:E, i.e., GFAP 
and astrocyte nuclei) as well as a membrane bound ligand (Fig. 3-7:F, i.e., 
NCAM) were observed. On the other hand, a network of astrocyte derived ECM 
proteins was preserved (Fig. 3-7:A, B, C and D). Similarly, positive type-1 Coll 
detection within oriented astrocyte derived ECM constructs was observed 
following decellularization (Fig. 3-7:A). In addition, even with ascorbic acid and 
ascorbate supplementation, mechanically stable, acellular, oriented astrocyte 
derived ECM constructs were only collectable when primary astrocytes after 
passage 2 or 3were used to engineer the cellularized constructs at the first place. 
The organized fibrillar structure of Coll and FN were found to be maintained in 
the acellular, oriented astrocyte derived ECM constructs (Fig. 3-7:A and B). The 
organized spatial arrangement of LN and CSPG in the oriented astrocyte derived 
ECM constructs was less obvious (Fig. 3-7:C and D).  
 
3.3.6 DRG Outgrowth on Oriented Astrocyte ECM Constructs 
 
Dissociated DRG neurons were seeded on acellular, oriented astrocyte 
derived ECM constructs to investigate whether simply the presence of a network 
of organized ECM proteins (i.e., FN and Coll) without the involvement of 












Fig.3-7: Representative ECM protein organization of acellular, oriented astrocyte 
derived ECM constructs. Organized fibrillar structure of type-1 Coll (A, in red) and 
FN (B, in green) were displayed in the ECM constructs following the 
decellularization. The anisotropic organization of CSPG (C, in green) and LN (D, 
in red) in the acellular ECM constructs was less obvious. (E). Little to no 
immunofluorescent signals of DAPI+ astrocyte nuclei (in blue) and astrocyte 
specific interfilament, GFAP (in green), were observed in the ECM constructs. (F) 
Decellularization effectively removed an astrocyte membrane bound ligand, 











After 2 days in culture, we observed that DRG neurite trajectories were generally 
extended in a preferred direction in a way similar to their outgrowth pattern on 
cellularized, aligned astrocyte constructs (Fig. 3-8:A). It should be noted that the 
presence of Schwann cells (Fig. 3-8:A, dark, slender shaped cell bodies) was 
always observed in our DRG preparation due to the limitation of our isolation 
technique, which might also contribute to providing guidance information to 
regenerating neurites. However, we found that the Schwann cells also generally 
showed biased orientation morphologically parallel to the long axis of the 
oriented astrocytes derived ECM constructs (i.e., parallel to the long axis of 
originally printed LN lane pattern, Fig. 3-8:A, arrows), suggesting that the 
organized ECM construct is capable of influencing the orientation of adjacent 
migrating and proliferating glial cells. 
 
3.3.7 Acellular, Astrocyte Derived ECM Tubular Constructs 
 
After the recovered astrocyte constructs were wrapped around plastic 
tubings and cultured for another week, the composite was decellularized to 
develop tubular astrocyte ECM constructs. Decellularization was performed while 
the plastic tubing was still attached. Following treatment, tubular ECM constructs 
with open lumens were obtained by removing the plastic tubings after 
lyophilization (Fig. 3-8:B and C). In contrast to the self-holding astrocyte tubes, 
the lumens of the tubular ECM constructs collapsed during rehydration, possibly 
due to the fact that there was not enough material present holding the wall 
structure (i.e., each acellular ECM tube was derived from an astrocyte construct 






Fig. 3-8: Representative images of DRG outgrowth behavior on oriented 
astrocyte derived acellular ECM constructs and engineered tubular astrocyte 
ECM constructs. (A) DRG neurite trajectories (shown in red) were found to 
generally extend in a preferred direction when cultured on the acellular, oriented 
astrocyte derived ECM constructs. The ECM construct was air dried on a 
coverslip and shown in the bright field. It should be noted that due to the 
limitation of our isolation technique, the presence of Schwann cells (dark, slender 
cell bodies indicated by arrows) in the DRG culture was always observed, which 
might also guide neurite outgrowth. However, the morphology of Schwann cells 
was also found to be generally aligned on the oriented astrocyte derived ECM 
constructs (i.e., parallel to the long axis of originally printed LN lane pattern), 
suggesting the organized ECM construct is capable of influencing the orientation 
of adjacent migrating and proliferating glial cells (B,C) Tubular astrocyte ECM 
constructs were prepared by decellularizing cellularized self-holding astrocyte 









Glial scar formation and inflammation-mediated cystic cavities are the 
hallmark cellular and molecular responses following SCI [26, 27], which interrupt 
the organized nerve fiber tracts at the injury site [1-4] and are manifested as 
major obstacles for axonal regeneration [4,6]. Various strategies including 
synthetic biomaterials [29], cell therapy [13-16] or combinational approaches [28] 
have been applied in an attempt to facilitate and guide axonal regeneration such 
that regenerating axons can reinnervate appropriate targets.  
Astroglial cells are the most abundant cell type in the CNS and appear as 
promising candidates for guiding neurite outgrowth utilizing biological 
mechanisms. Astroglial cells have been suggested to crosstalk with pioneering 
axons temporally and spatially by arranging into organized glial frameworks and 
extending their processes parallel to the presumptive fiber tracts at specific 
periods during development [35-39] or acting as guidepost cells to guide axonal 
trajectories [40]. Astrocytes have also been shown to serve as supportive 
substrates for various types of neuronal cell outgrowth in vitro [43,44]. Cell 
transplantation studies have also demonstrated the beneficial roles of young 
astrocytes in promoting SCI repair [32-34].  
Moreover, organized glial structures have been found to effectively 
facilitate and guide regenerating axonal trajectories following injury in both 
mammalian and nonmammalian animal SCI models [2,4,6,13,15-19,24,25,45]. 
While these observations led to a number of studies where astrocyte monolayer 





vitro [20-24, 55], it is unclear if such organized astrocyte structures could be 
transferred for in vivo applications. 
In the current study, we developed 3D astrocyte constructs, either 
randomly organized or aligned, that are mechanically stable and implantable to 
address such issues. The astrocyte constructs were engineered simply by 
repeatedly seeding cells atop previous cell layers. In particular, our in vitro results 
showed that the orientation of overlying migrating and proliferating astrocytes can 
be organized by a previously established oriented astrocyte structure, suggesting 
such constructs are potentially capable of organizing the disorganized glial scar 
tissue during its maturation in vivo.  
Thermo-responsive polymer, poly(N-isopropylacrylamide) (PIPAAM), 
treated surfaces have been the culture substrates of choice for engineering 
continuous cell sheets and protein patterning as well as grafted polymer brushes 
onto PIPAAM surfaces has been applied to induce the organized structure of cell 
sheets [57, 60]. In the current study, we demonstrated that plain coverslips are 
also suitable substrates for harvesting multilayered cellular constructs, with or 
without morphological alignment. This is advantageous as the cost of purchasing 
PIPAAM grafted substrates and the potential undesired cell sheet detachment 
due to ambient temperature drop during cell seeding can be avoided. 
The aligned astrocyte constructs hold several advantages over traditional 
cell therapy approaches. First, the desired astrocyte orientation can be 
engineered within the aligned constructs, which has been suggested to facilitate 





to the overall cellular orientation via injection of cell suspensions. Second, the 
astrocyte constructs were harvested along with deposited ECM ligands which 
have been shown to play an important role in mediating neurite outgrowth during 
development as well as following injury [25,41,42,55]. Tessier-Lavigne and 
colleagues [46] first proposed that extracellular matrix molecules could act as 
short range guidance cues for directing neurite outgrowth. Therefore, having an 
organized ECM network upon implantation should be advantageous as guidance 
cues can be readily available for regenerating axons. It has been reported that 
the axonal regeneration is observed as early as 6 hrs following injury [49]. 
Moreover, a transplantation study has demonstrated that implantation of ECM-
associated cellular grafts resulted in superior regeneration outcome to injection of 
cell-only suspensions [47]. 
In addition, oriented astrocyte constructs can be decellularized to reduce 
the undesired immunogenic response associated with allogeneic or xenogeneic 
cellularized materials upon implantation [54]. Cell-deposited ECM materials are 
generally considered to be immunologically tolerable between species and have 
been used as an alternate to cell therapy for various regenerative medicine 
applications [30,31,50,53]. Following decellularization, acellular, oriented 
astrocyte derived ECM constructs were obtained and positively stained for 
various ECM proteins whereas little to no signals of either intracellular 
components or cell membrane-bound ligands were seen immunofluorescently, 





Interestingly, we found that ascorbic acid and ascorbate treatment was 
needed for astrocytes to deposit enough matrix materials so that acellular ECM 
constructs can be collected following decellularization. This observation could be 
explained by the positive type-1 collagen detection within the cellularized and 
acellular astrocyte constructs following ascorbic acid and ascorbate 
supplementation, which would contribute to the mechanical properties of the 
ECM materials. The association between primary astrocytes and type-1 collagen 
has been previously reported in the literature [59]. In addition to the ascorbic acid 
and ascorbate supplementation, using primary astrocytes after passage 2 or 3 
were also required for acellular ECM constructs collection following 
decellularization, suggesting that astrocytes might secrete more collagen as they 
mature in vitro. This hypothesis is supported by our finding that no stable ECM 
materials can be collected from young astrocytes (e.g., no passage) even in the 
presence of ascorbic acid and ascorbate treatment.  
In particular, the spatial organization of type-1 Coll and FN within the 
acellular ECM constructs maintained an organized fibrillar structure, suggesting 
that the oriented ECM constructs would still preserve the ability to guide neurite 
trajectories since we have previously shown that astrocyte associated FN plays 
an important role in guiding neuronal pathfinding in vitro [55]. 
Indeed, both cellularized, aligned astrocyte constructs and acellular, 
oriented ECM constructs directed regenerating DRG outgrowth in vitro. As 
indirect immunohistochemical reactions demonstrated the successful removal of 





suggests that the directional information carried by the organized ECM matrices 
alone is sufficient to guide neuronal pathfinding. In the present study the 
presence of Schwann cells was always observed in our DRG preparation due to 
the limitation of our isolation technique, which might also contribute to providing 
guidance for DRG neurite outgrowth. However, the fact that Schwann cells on 
the decellularized aligned ECM constructs were also observed to generally 
exhibit oriented morphology in vitro further strengthens our hypothesis that the 
oriented astrocyte derived ECM constructs could potentially influence and 
organize the orientation of adjacent proliferating and invading glial cells at injury 
sites in vivo. 
ECM is also known to serve as reservoirs for cell secreted growth factors 
[59] and astrocytes have been shown to secret a variety of neurotrophic factors 
such as NGF, FGF, and IGF [52]. Thus upon construct degradation, these growth 
factors could be potentially released and acted as inductive cues to modulate 
surrounding cell functions. Moreover, acellular ECM based biomaterials have 
been shown to result in superior regeneration outcome when compared to 
cellularized biomaterials [53]. In contrast to the predominantly M1 inflammatory 
macrophage phenotype seen at the implantation site induced by the cellular 
grafts, acellular ECM grafts resulted in a primarily M2 antiinflammatory 
macrophage phenotype and organized connective tissue remodeling [53]. It has 
been demonstrated that M1 inflammatory macrophages predominate the lesion 
site starting 14 days following contusive SCI and cause neurotoxicity to 





promote axonal outgrowth on inhibitory substrates in vitro [58].Thus, implantation 
of astrocyte derived acellular ECM constructs following SCI could potentially 
increase the M2/M1 macrophage ratio at the injury site. 
In addition, presenting tissue specific biological cues to tissue type 
matched cell types have been shown to be important for maintaining 
appropriately differentiated cellular characteristics [49,56]. Thus, it might be 
potentially advantageous using biomaterials derived from neural cells in the CNS 
for regenerative medicine applications in the CNS due to the fact that they would 




Both cellularized and acellular oriented astrocyte based biomaterial 
constructs were engineered in vitro in the present study. As oriented astrocyte 
based biomaterials are capable of organizing proliferating glial cell orientation 
and guiding neuronal pathfinding and might carry a network of neural tissue 
specific biological cues, these in vitro results suggest the possible therapeutic 
applications of these oriented astrocyte based biomaterials as novel tissue 
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4.1.1 Dural Defect 
 
Dura mater is the outermost layer of the meninge tissue and dural defects 
often occur as a result of trauma resection and other surgical procedures [1-3]. 
The consequence of such injury is the exposure of underlying isolated central 
nervous system (CNS) tissue, which increases the possibility of further infections. 
Thus, it is the general surgical practice to repair dural defects to restore normal 
tissue homeostasis and barrier functions  
On the other hand, a different opinion, based on both experimental and 
clinical works, supports the idea that dural defect repairs itself without the need of 
a surrogate replacement [4, 5]. Similar to standard wound healing scenario found 
in other tissues, inflammatory cell infiltration is observed to first arrive the lesion 
site, followed by fibroblast proliferation and migration, and new connective tissue 
deposition becomes the major healing process 1 week following injury [6]. Trotter 
and colleagues first demonstrated in a clinical study that the dural defect was 
completely repaired by itself in a few weeks after a partial excision and 





[5]. The same conclusion is also supported by others based on their study on 
dogs [4]. 
Although some researchers hold the idea that dural defects self-repair and 
it is unnecessary to replace the defect area with foreign materials, serious 
complications associated with dural defects have been reported in the literature. 
Meningocerebral adhesion is one common dural defect associated complication. 
It occurs due to the formation of adhesions between exposed brain tissue and 
overlying skull lining connective tissue layer [7] and this adhesion formation is 
involved in inducing posttraumatic epilepsy [7, 8]. Cerebral fungus is another 
complication associated with dural defects [9], which increases the tendency of 
brain tissue herniation through the wounded site. The craniocerebral erosion is a 
rather rare pathological condition related to dural defects where skull erosions 
are observed in areas corresponding to underlying dural defects [10] The most 
serious pathological complication accompanying dural defects are meningitis 
and/or extradural abscess, which occur as a result of bacterial infection from the 
cerebrospinal fluid (CSF) leakage induced secondary contamination[11].  
Due to the occurrence of the above mentioned complications, replacing 
dural defects with grafting materials appears the dominant opinion among 
neurosurgeons. It was stated by Teng and Feign that “The chief purpose of using 
a dural substitute in neurosurgery is to prevent adhesions between the exposed 
brain and the overlying soft tissues rather than to fill the defect in the severed 





Ideal materials as dural substitutes were sought beginning in the early 
19th century and a variety of biomaterials have been evaluated for suitability to 
repair such defects.  
 
4.1.2 Non-Natural Materials as Dural Substitutes 
 
4.1.2.1 Inorganic materials as dural substitutes. Different inorganic 
metallic foils were first explored as potential dural substitutes because they are 
thin, soft and have smooth surfaces [7, 8, 13-17]. Gold foil was the first metallic 
material proposed as dural substitutes to prevent the formation of 
meningocerebral adhesions that causes postoperative epilepsy and the surgical 
procedure was performed in a patient [13]. However, the patient was readmitted 
due to the returned convulsion. This recurrence of convulsion following gold foil 
implantation has also been reported by others [14]. Silver foil was shortly 
pursued by neurosurgeons as dural surrogates for the same purpose. In a study, 
the patient was released after duraplasty and remained healthy for at least 1 year 
[7]. Tantalum foils were studied in the 1940s as potential dural surrogates [15, 
16]. Although a dense fibrous encapsulation around the tantalum foil was 
observed in dogs, a clinical study showed only fine and thin fibrous envelope 
enclosing the graft, which made the authors advocate the use of tantalum foils for 
dural defect repair in humans [16]. A comprehensive study was done by Chao 
and colleagues where the performance of a number of metallic materials as dural 
substitutes was compared, including aluminium, silver, nickel and stainless steel 
foils [8]. It was found that although meningocerebral adhesions are avoided 





response, including dense connective tissue envelopes, presence of foreign body 
giant cells and cerebral scar tissue formation. While metallic foils were popular 
materials in the early 19th century for preventing postoperative adhesions, their 
use was soon discontinued due to the strong foreign body responses.  
4.1.2.2 Synthetic materials as dural substitutes. Rubber tissue was the 
first synthetic material investigated for dural repair to prevent meningocerebral 
adhesions and epilepsy [18, 19]. While Abbe and colleagues reported a dense 
development of granulation tissue around the implant, which eventually broke the 
rubber and enclosed the fragments, Haynes and colleagues used similar rubber 
material to repair defects after a spinal cord tumor removal and reported that the 
patient were recovered uneventfully [19]. Polyethylene (PE) films were explored 
as dural substitutes as it was suggested that a versatile material would be 
needed for different duraplastic surgery situations [20]. The material was applied 
on dogs and monkeys where only nonadherent, neomembranes were found 
around the grafts and no foreign body giant cells were observed. It was also 
successfully applied in humans [20].  
The synthetic acrylic fiber Orlon has also been evaluated as dural 
surrogates on monkeys [21]. The Orlon was found loosely adherent to the skull 
without fibrous encapsulation and foreign body giant cell presence. However, 
Orlon was found firmly attached to the bone 15 months after surgery. Clinically, a 
patient who received an Orlon implant was reported to remain healthy for at least 
3 months. In addition, Vinyon N was tested as dural substitutes on monkeys with 





meningocerebral adhesions or convulsions were found following implantation 
even in animals with injured cortical tissues and the materials could be easily 
separated from the cortex. 
Expanded polytetrafluoroethylene (ePTFE) is a nonabsorbable material 
extensively studied both experimentally and clinically for repairing dural defects 
[22-24]. In one clinical study with 34 patients, ePTFE dural substitutes were 
sutured to the defect site and later on easily detached from the overlying 
connective tissue layer during reoperation. Microscopically, ePTFE was found to 
be encapsulated by a thin sheet of connective tissue and in associations with 
minimal adhesions [24]. Recently, the feasibility of a modified version of ePTFE 
dural substitutes, GORE PRECLUDE® MVP®, was examined [25]. One side of 
the modified ePTFE is engineered to facilitate fibroblast migration and 
proliferation while the other surface limits cell/tissue adhesion. The material was 
used as “underlay” graft in 59 patients with at least 4 months follow-up and good 
recovery outcome was reported for all patients. However, a higher rate of wound 
related complications was noticed, which the authors claimed can be avoided by 
close positioning of the graft to the overlying dural tissue.  
Hydrogels made of poly-hydroxyethylmethacrylate (poly-HEMA) as dural 
surrogates have also been investigated [26]. HEMA hydrogels were used as 
overlay dural repairing materials without suturing in rats with damaged brain 
tissues. Neither adhesion formation nor CSF leakage was observed in animals 
that received hydrogel implantation whereas mild to severe brain herniation was 





The performance of biosynthetic cellulose for dural defects repair hasalso 
been evaluated and reported [27]. Biosynthetic cellulose was found to effectively 
prevent meningocerebral adhesions and convulsions even when underlying brain 
tissues were damaged. However, moderate fibrosis enclosing the graft was 
observed, which caused the cellulose graft adherent to the bone.  
Recently, Xie and colleagues investigated the therapeutic potential of 
radially aligned poly (-caprolactone) nanofibers for repairing dural defects[28]. 
They showed that radially aligned nanofibers facilitated dural cell migration to the 
graft center in vitro; however, no in vivo data were reported. Kurpinski and Patel 
studied both random and aligned nanofibrous dural substitutes and reported that 
neither adhesions nor inflammatory response adjacent to or at the implantation 
sites was found in all groups except along the suture line where the graft was 
sutured [29]. In particular, the authors found that aligned nanofibrous dural 
substitutes induced a more consistent and thicker connective tissue deposition 
than random substitutes across the durotomy site.  
Synthetic, biodegradable polymers have been studied as dural substitutes 
to avoid the chronic inflammatory response commonly associated with non-
absorbable materials. Vicryl (polyglactin 910) was found to be significantly 
absorbed 40 days following implantation in dogs with little meningocerebral 
adhesions and modest inflammatory response noticed [30]. The graft zone was 
completely replaced by fibrous tissue deposition and no chronic inflammatory 





material, was also evaluated in the same study and appeared to elicit a similar 
but greater inflammatory reaction [30].  
Synthetic dural substitutes made of GM972 (i.e., composite material 
composed of 50% polylactic acid/50% caprolactone and polyglycolide acid 
nonwoven fabric) was found to be completely absorbed within24 weeks with no 
adhesions noticed. In addition, the authors reported that no inflammatory 
response associated with graft degradation was observed [31]. Clinically, no 
patients were reported to suffer from infection following GM972 implantation and 
CT scan showed no abnormal signs surrounding implantation site during a 2-12- 
month follow-up [32]. However, it was shown in a separate clinical study that 
some patients experienced subcutaneous CSF accumulation, hemorrhage or 
tumor recurrence and needed reoperation [33].  
4.1.2.3 Complications associated with synthetic dural substitutes. While 
synthetic materials are widely used for duraplasty, there are still concerns 
regarding their safety. In 1983, Adegbite and colleagues reported a case of post-
operative complication in association with silastic dural substitutes that were 
implanted to repair dural defects generated due to meningioma removal [34]. The 
patient was experiencing headaches, mental deterioration and confusion. The 
symptoms were attributed to the hematoma formation in the neomembrane 
enclosing the silastic dural substitute. Similar pathologies associated with the use 
of silastic material for dural reconstruction have also been reported by other 
studies [35-37]. Since the loosely adherent neomembrane is often observed 





due to the breakage of vessels in the neomembrane, caused by relative 
movement between the surrounding connective tissue and the silastic material 
[38]. Hematoma formation has also been observed in one patient who received 
Dura Film (i.e., silicone-coated Dacron) to repair a defect after tumor removal 
[39]. In a separate case, the development of thick connective sheath associated 
with silastic substitutes was postulated to stimulate recurrent tumor 4 years after 
the patient’s first surgery for tumor removal [39]. Recurrence of meningioma has 
also been reported due to progressive compression to the brain tissue generated 
by the growing fibrous tissue 20 years after a patient received Marlex mesh (i.e., 
crystalline polypropylene and high-density polyethylene) following tumor removal 
[40] 
Although Neuropatch®(i.e., purified polyester-urethane)has been reported 
to be a suitable material for dural defect repair in a clinical study [41], it has also 
been documented in the literature that it causes a higher incidence of wound site 
infection than pericranium grafts [42]. Despite the fact that the higher infection 
rate is not significant, Neuropatch is reported to be in association with a 
significantly higher CSF leakage rate [42]. Additionally, Neuropatch has been 
reported to be associated with either tumor recurrence or intense inflammatory 
reactions due to bacterial contamination [43]. Recently, Huang and colleagues 
reported that, instead of inducing a higher rate of wound site infection and CSF 









4.1.3 Natural Materials as Dural Substitutes 
 
4.1.3.1 Animal membranes as dural substitutes. In 1938, Glaser and 
Thienes studied the possibility of using either heteroplastic or autoplastic 
membranes as dural substitutes [45]. The authors reported that the inflammatory 
reaction associated with both types of membranes was still evident after 9 
months and both materials were then incorporated by 12 months. Only slight 
adhesion formation was seen when the underlying brain tissue was damaged. 
Chao and colleagues compared a series of animal membranes for dural defect 
replacement on cats with injured pia mater [8]. Among all materials tested, they 
recommended the use of aminotic membranes for human clinical studies based 
on their observations that aminotic membranes induced the least adhesion 
formation and were incorporated to form new dural tissue. Carglie membranes, 
on the other hand, were found to stimulate dense adhesion formation when the 
underlying pia mater was damaged [8]. Contrary to Chao’s observation, Pudenz 
and Odom reported that, instead of preventing adhesions, different types of 
aminotic membranes(i.e., viable, fixed, attenuated) actually stimulated adhesion 
formation [17]. Their conclusions were supported by another study [46].  
Lyophilized human cadaveric dura was a popular dural surrogate in the 
1960s [47-50]. In general, inflammatory response is found in association with the 
lyophilized dura for the first few weeks, then the material is infiltrated by 
fibroblasts along the natural pores of the graft and gradually replaced by fibrous 







reported to have low incidence of infection, low CSF leakage rate and minimal 
foreign body response in clinical studies [49, 50]. 
The usefulness of acellular dermal graft from human cadaveric skin as 
dural substitutes has also been explored [51-53]. Faster incorporation of acellular 
dermal grafts by native dural tissue has been observed when compared to 
autologous pericranium grafts in minipigs [51]. Histologically, acellular dermal 
grafts have been reported to result in deposition of organized, fibrous structure 
similar to the native dura whereas autologous pericranial tissue leads to 
disorganized collagen fiber deposition. When tested clinically, the material has 
been reported to be associated with similar infection rate as autologous tissue 
and low incidence of CSF leakage was noted [52].  
Based on the successful applications of small intestinal submucosa (SIS) 
in repairing soft tissues, SIS has been examined as dural substitutes [54, 55]. 
SIS has been found to induce significantly more vascularization following 
implantation compared to control sites where dural defects were left open [54, 
55]. The predominant cell type seen populating the grafted area following SIS 
resorption has been shown to be spindle shaped, mesenchymal cells [54]. 
Glutaraldehyde fixed porcine peritoneum has been reported to facilitate 
water tight closure when used for dural repair in dogs [56]. No meningocerebral 
adhesions were observed following implantation. However, the peritoneal 
membrane was found to form adhesions to the overlying temporal muscle layer. 
Fibrous encapsulation and neovascularization around the implant were also 





Although glutaraldehyde fixed porcine peritoneum was shown to be suitable for 
dural closure in animal studies, the glutaraldehyde fixation process has been 
found to cause the hyperthermic reaction in humans [56]. However, apart from 
this side effect, patients were reported to experience uncomplicated recovery up 
to five years. 
In addition to porcine peritoneum, pericardium of either porcine or bovine 
origin are also of interest [50, 57]. The pericardial membrane has been found to 
undergo similar tissue reactions as the peritoneal graft when applied as dural 
substitutes in rabbits [57]. In a clinical study, no patients were reported to 
experience antigenic response following implantation. The autopsy showed 
fibroblast migration through interstitial pores within the graft with neocollagen 
deposition and only a small piece of the material was seen after 24 months [50].  
While earlier clinical studies showed that autologous fascial grafts were 
applicable for dural defect repair [58], Tachibana and colleagues evaluated the 
healing process of the dural tissue following fascial graft implantation 
experimentally [59]. In particularly, they studied the effect of overlying 
subcutaneous tissue on facilitating dural regeneration. When compared to 
ePTFE, defect sites reconstructed by fascial graft held significant higher 
intracranial pressure. The fascial graft was first encapsulated by dense 
connective tissues that connected the graft to the surrounding dura mater and 
then being incorporated. They also observed faster dural tissue regeneration with 
the presence of overlying subcutaneous tissue; however, dural tissue 





4.1.3.2 Collagen based products as dural substitutes. Acellular, collagen 
based materials that are either chemically processed or modified have drawn a 
lot of attention in the field of duraplasty because they possess several 
advantages over cellularized animal membranes and cadaveric dura. Collagen is 
generally considered to be immunologically tolerable between species and its 
structure acts as scaffolds that support cell migration, proliferation and deposition 
of new connective tissue. Moreover, they can be easily stored and are relatively 
inexpensive. These collagen based products also avoid the potential disease 
transmission that has been reported in association with both cellularized animal 
membranes and cadaveric dura [71, 72, 74]. 
Processed collagen films and laminates as dural substitutes were first 
evaluated by Kline and Jannetta [60, 61]. In both studies, the authors reported 
that collagen laminates appeared to result in a more intensive fibrosis 
encapsulation when compared to collagen films and the laminate structure also 
induced more meningocerebral adhesions. Either collagen films or laminates 
were found fully degraded following implantation; however, the collagen laminate 
has been shown to have a slower degradation rate. Foreign body response (FBR) 
has also been noted in different studies when collagen film laminates were used 
as dural substitutes [62, 63].  
Narotam and colleagues conducted comprehensive studies on using 
collagen sponge as dural substitutes and described a serious of cellular events 
following collagen sponge implantation [64, 65]. Microscopically, they observed 





formation during the first 2 weeks. The fibroblast activity and neovascularization 
were well established by 30 days, which were then followed by collagen sponge 
resorption and complete incorporation of the material by native dural tissue after 
6 months. Similar responses have also been reported in an animal study [64].  
Dura-guard®, Duragen® and Durepair® are three commercially available, 
collagen based dural substitutes of bovine origin [66]. Among these three 
products, only Durepair® is not chemically crosslinked. Depending on the nature 
of the original tissues, Duragen® has the largest interstitial pore size (100 μm), 
followed by Durepair® (10-20 μm) and Dura-guard® (5 μm). When tested in dogs, 
the interstitial pore size was found to play an important role in affecting substitute 
degradation where Duragen® degraded the fastest (1 month), followed by 
Durepair® (6 months) and Dura-guard remained largely intact even after 6 
months. Similarly, Dura-guard® has been shown to remain intact after 6 months 
in rabbits with strong fibrosis encapsulation, which was suggested to cause 
compression to the rabbit brain tissue [67].  
Tissudura® is another commercially available collagen based dural 
substitute that is transparent and primarily composed of uncrosslinked equine 
type I collagen. It has been applied both in experimental animals and human 
subjects [68-70]. In sheep, Tissudura® has been shown to induce an intensive 
acute inflammatory response, followed by graft degradation and the continuity 
between the native dura mater and newly deposited collagen matrices was well 
established after 8 weeks [68]. In clinical studies, CT scan and MRI were used to 





received Tissudura®[69, 70]. Parlato and colleagues reported no such 
complications were found during a 1-year follow-up [70] whereas several cases 
of CSF leakage were reported by Gazzari and colleagues as early as 7 days 
postsurgery [69].  
4.1.3.3 Complications and limitations associated with natural dural 
substitutes. While lyophilized, cadaveric dura has been applied as dural 
substitutes with low incidence of postoperative complications [47-50], its 
association with the Creutzfedlt-Jacob disease (CJD), which causes infected 
brain tissue developing holes and turning into sponge-like structure, has been 
reported [71, 72]. In addition, immunogenic reactions developed in patients 
against the implanted cadaveric dura has also been documented [73]. Moreover, 
the preparation and storage of such material are time consuming and expensive.  
Autologous grafts, such as fascia lata, temporalis fascia and pericardium, 
have the advantage over xenografts and allografts as they are nonimmunogenic. 
However, the availability of autologous grafts is limited and may be insufficient 
when the dural defect area is large. Additionally, a second surgical operation is 
needed for graft harvesting, which would prolong the surgical and anesthetic time 
and may lead to painful donor sites.  
Cellularized animal membranes, which have abundant availability, have 
been reported to induce intensive adhesion formation [8, 17]. The possibility of 
disease transmission or material associated immunogenicity also limits their 
application [74, 75]. Besides animal membranes, different forms of human 





induce dense cerebromeningeal adhesions and not recommended for clinical use 
[17, 46]. 
Collagen based products generally show satisfactory outcomes when 
used as dural substitutes. They hold several advantages such as inducing 
minimal inflammatory response, avoiding chronic FBR due to their resorbable 
nature and acting as biological scaffolds that support cell proliferation and 
migration. However, the laminate structure of collagen products has been shown 
to induce intensive inflammatory reactions, fibrotic encapsulation as well as 
adhesion formation [60, 61]. Moreover, the natural interstitial pore size within the 
collagen based dural substitutes also affects the host tissue responses. Among 
three commercially available collagen products, Dura-guard®, which has the 
smallest interstitial pore size (5 μm), has been shown to result in fibrosis 
encapsulation similar to nonresorbable synthetic materials [66].  
 
4.1.4 Advantage of Tissue Specificity in Regenerative Medicine 
 
ECM materials are generally accepted to induce minimal immunogenicity 
and have been widely applied in regenerative medicine applications [76-78]. 
Although ECM materials derived from different tissue/organ sources share 
common protein components, subtle difference still exists, which has been 
shown to influence cellular functions[79]. Therefore, the idea of using tissue 
specific ECM that carry appropriate biological cues to facilitate the regeneration 
of tissues targeted for repair has become increasingly popular [80-84]. Studies 
have shown that tissue type specific ECM coatings perform superior ability to 





differentiated cellular characteristics as the specific ECM coatings better mimic 
the native extracellular milieu in vivo[82, 83]. The importance of the specificity of 
acellular ECM scaffolds has also been emphasized by a study where 
implantation of ECM materials derived from a different tissue origin resulted in 
formation of foreign tissue types at the repair site [85]. It is believed that the 
foreign tissue formation is due to the presence of inappropriate biological cues 
introduced by the implanted ECM materials, which fails to provide tissue specific 
regeneration. It has also been demonstrated previously that myocardial tissue 
matrices promoted migration of both human coronary endothelial cells and rat 
aortic smooth muscle cells, two myocardial tissue specific cell types [84]. 
In addition, implantation of acellular, ECM scaffolds, even of allogeneic or 
xenogeneic sources, has been shown to lead to constructive tissue remodeling in 
defect areas with infiltrating macrophages being predominantly antiinflammatory 
M2 phenotype. On the other hand, cellularized grafts have been found to be 
accompanied by primarily inflammatory M1 macrophages and lead to dense 
connective tissue deposition and scar formation [86].  
Given this knowledge, in the present study, 3D biological constructs were 
engineered using postnatal day 1 (P1) rat meningeal fibroblasts, the most 
abundant cell type residing in the meninges tissue, including the dura mater. The 
constructs were evaluated for suitability as dural substitutes in vitro. Indirect 
immunohistochemistry was used to compare the extracellular matrix protein 





based assays were used to examine the suitability of the construct to support cell 
adhesion, proliferation and migration into the construct.  
 
4.2. Materials and Methods 
 
4.2.1 Rat Meningeal Fibroblast and Dural Tissue Isolation  
 
Primary postnatal day 1 (P1) rat meningeal fibroblasts were isolated from 
the cranial meninges of Sprague-Dawley rats as previously described [87]. Briefly, 
rat meningeal tissue was peeled from the surface of the cerebral cortices, then 
digested in collagenase for 30 mins (0.33% w/v), followed by 30 mins trypsin-
EDTA treatment (0.25% w/v, Invitrogen) and dissociated by repeated trituration in 
DNase (0.1% w/v, Worthington Biochemical) through a fire-polished pipette. After 
trituration, dissected cells were plated in T-75cm2 tissue culture flask (Greiner) in 
DMEM/F12 containing 10% fetal bovine serum (FBS, Sigma) and grown to 
confluence. Adult rat cranial dura mater was also prepared by peeling it from the 
inner surface of the skull from adult Sprague-Dawley rats separately.   
 
4.2.2 Engineering and Harvesting 3D Meningeal Constructs 
 
Primary rat meningeal fibroblasts were seeded on sterilized glass 
coverslips at a density of 52,000 cells/cm2 in 10% FBS supplemented with 
ascorbate-2-phosphate (150 μg/ml, Sigma) and ascorbic acid (50 μg/ml, Sigma) 
to promote collagen deposition and maturation. After the first meningeal 
fibroblast layer reached confluence, subsequent seeding was applied on the 
confluent cell layer at the same density. This seeding process was repeated 





culture medium was replaced with fresh medium supplemented with ascorbate-2-
phosphate (150μg/ml) and ascorbic acid (50μg/ml) the day following cell seeding. 
Dense 3D meningeal constructs were harvested after 12-16 days of culture. 
Hydrophilic membranes (Cellseed) were put atop of the apical surface of dense 
meningeal constructs and the constructs were detached from the coverslips by 
gently peeling off the membrane with forceps. Excess culture medium was added 
to separate the membranes from recovered constructs. Harvested meningeal 
constructs were fixed using 4% paraformaldehyde for 15 mins. Several 
meningeal constructs were harvested without membranes via gently scratching 
the coverslips surface using forceps and recovered constructs were again fixed 
with 4% paraformaldehyde.  
 
4.2.3 Decellularization of Engineered Meningeal Constructs  
 
Harvested meningeal constructs with attached membrane were placed in 
hypotonic Tris-Hcl buffer (10 mM, pH 8.0) with 0.1% EDTA and 10 KIU/ml 
aprotinin (Sigma) for 1-2 hrs at room temperature (R.T.) to disrupt integrin-ECM 
interactions and deactivate proteases that were released due to cell body rupture. 
Then, samples were immersed in Tris-Hcl buffer containing 0.1% sodium dodecyl 
sulfate (SDS) (10 mM, pH 8.0) on a rocker at 100 rpm at R.T overnight to 
dissolve lipid membranes with supporting membranes removed. Following SDS 
treatment, samples were rinsed three times, 30 mins each, in PBS on a rocker. 
Last, samples were treated with Tri-Hcl buffer (50 mM, pH 7.5) containing 





rocker at 37oC for 3 hrs to break down DNA and RNA. Samples were again 
rinsed with PBS three times, 30 mins each, on a rocker.  
 
4.2.4 Cell Culture on Decellularized Meningeal ECM Constructs   
 
Decellularized meningeal ECM constructs were first air-dried in the center 
of the 35 mm glass-bottom dish (World Precision Instruments). Allogeneic 
primary rat meningeal fibroblasts were seeded at 35,000 cells/dish in 2 ml 
DMEM/F12 with 10% FBS. Allogeneic meningeal fibroblasts were cultured for 2 
days and then fixed with 4% paraformaldehyde.  
 
4.2.5 Histological Sectioning  
 
Agar powder (Gibco) was dissolved in warm D.I. water to make a final 
concentration of 0.8% agar solution. Meningeal constructs were placed in a 
square mold and warm 0.8% agar solution was slowly poured into the mold to 
cover the samples. The agar solution was then cooled and solidified. Solidified 
0.8% agar cubes were removed from the mold with samples embedded and 
infiltrated in 30% sucrose solution overnight. Agar cubes were then put on 
cryostat specimen holders at the desired orientation. Tissue freezing medium 
(Triangle Biomedical Science) was added to cover the agar cubes, and the 
specimens were placed in the cryostat at -20oC. Specimens were cut 
transversely into 15 m thick sections. 
 
4.2.6 Tissue Thickness Measurements 
 
Adult rat native dura mater, as well as 6 and 8 seeding engineered 







15 μm thick sections as described in section 2.5. Image J software was used to 
measure the thickness of the cross-sections of each embedded sample with a N 
= 3 from each group.   
 
4.2.7 Quantification of Meningeal Fibroblast Adhesion and  
 
Proliferation on Decellularized Meningeal ECM Constructs 
 
Acellular meningeal ECM constructs were first air-dried on 18mm 
coverslips. For cell adhesion assay, dried ECM constructs were coated with 4% 
Bovine serum albumin (BSA) solution for 3 hrs at 37oC to block nonspecific cell-
ECM interactions and then rinsed with sterile PBS prior cell seeding. Astrocytes 
and meningeal fibroblasts were seeded at a density of 52,000 cells/cm2 in 1 ml 
DMEM/F12 supplemented with 10% FBS for 90 mins and then fixed with 4% 
paraformaldehyde. Coverslips coated with 4% BSA were seeded with meningeal 
fibroblasts at the same density for comparison.  All groups were rinsed with 
sterile PBS once prior to cell fixation. DAPI+ cell nuclei were used as the 
indicator for cell number quantification. Ten 10X fluorescent images were taken 
at different locations from each coverslip. A built-in function of ImagePro (Media 
Cybernetics) was used to count the number of DAPI+ nuclei from each image. 
There were N=3 for each group for analysis. 
For cell proliferation assay, meningeal fibroblasts and astrocytes were 
seeded on the dried meningeal ECM constructs, respectively, at a density of 
52,000 cells/cm2 in 1 ml DMEM/F12 supplemented with 10% FBS for 4 days. 
Meningeal fibroblasts were also cultured on 10% FBS coated coverslips for 





sterile PBS once. Half of the coverslips from each group were fixed after 2 days 
and the other half were fixed after 4 days in culture. DAPI+ cell nuclei were used 
as the indicator for cell number quantification. Ten 10X fluorescent images were 
taken at different locations from each coverslip. A built-in function of ImagePro 
(Media Cybernetics) was used to count the number of DAPI+ nuclei from each 
image. There were N=3 for each group at each time point. 
 
4.2.8 Immunohistochemical Analysis 
 
For intracellular antigens, samples were treated with 0.05% Triton X-100 
in PBS for 15 min and then rinsed with PBS. No Triton was applied for 
immunohistochemical staining for extracellular matrix ligands. When intracellular 
ligands were co-stained with extracellular ligands, extracellular ligands were 
always processed first, followed by Triton treatment and then the 
immunohistochemical reactions for intracellular ligands were processed. For 
indirect immunohistochemical reactions, cryostat sections were rinsed with PBS 
to remove tissue freezing medium. Samples were treated  with 4% goat serum 
and 0.1% sodium azide in PBS for 1 hr and then incubated with primary antisera 
against laminin (LN; Sigma; 1:500), cellular fibronectin (CFN; Sigma; 1:500), 
chondroitin sulfate proteoglycan (CS-56; Sigma; 1:500) and type-1 collagen (Coll; 
Sigma; 1:500). Fluorescent dye conjugated secondary antibodies (Molecular 
Probes) were applied at dilution of 1:500. All antibodies were diluted in 4% goat 
serum /0.1% azide and applied for 24 hrs at room temperature. Three washes 
with 30mins each were applied between applications of primary and secondary 





Tissue sections were mounted on microscope slides covered with Fluormount-G 
(Southern Biotech), and coverslipped. Images were acquired using a Nikon 
epifluorescence microscope equipped with a CCD camera (ImagePro) or using 
an Olympus FVX laser scanning confocal microscope when noted. 
 
4.2.9 Statistical Analysis 
 
All quantitative data were reported as the mean ± standard deviation. One 
way ANOVA was used to compare the means. p values < 0.05 were considered 




4.3.1 Characterization of Native Adult Rat Dura Mater 
 
Indirect immunohistochemical reactions demonstrated that harvested 
native adult rat dura mater were positive for several major ECM proteins 
including type-1 Collagen (Coll), chondroitin sulfate proteoglycan (CSPG), 
fibronectin (FN) and laminin (LN) (Fig.4-1:A, B, C and D). In particular, the fibrillar 
structure of type-1 Coll was clearly seen in the rat dura mater. The thickness of 
adult rat dura mater was approximately 100 μm (Fig. 4-2) and the vasculature 
network of the rat dura mater can be clearly seen with the LN staining which runs 
through the tissue (Fig. 4-1:D and F). The multiple layers of DAPI positive cell 
nuclei shown in the cross-sectional image demonstrated the multilayered cellular 










Fig.4-1:Representative extracellular matrix protein profile of native adult rat dural 
mater, adult rat dural mater was positively reacted with antisera against type-
1Coll (A, in green), CSPG (B, in red), FN (C, in green) and LN (D and F, in red). 
The cross-sectional image of adult rat meninges showed multilayered cellular 
structure (E). Vasculature network are seen running through in some areas of the 
dura (D, F). Occasionally, cellular alignment was observed in the dural mater (B, 
top half of the image). DAPI was used for nuclei observation (A-E, in blue). Scale 









Fig.4-2:Thickness comparison of native adult rat dural mater, 6 seeding and 8 
seeding engineered meningeal cell constructs. There was a statistical significant 
difference in the thickness between any two groups (ANOVA, post hoc, p<0.05). 
 
 
4.3.2 Engineering 3D Multilayered Meningeal Fibroblast Constructs 
 
The procedure of engineering each multilayered meningeal fibroblast 
construct is illustrated in Fig. 4-3A. Primary rat meningeal fibroblasts were 
seeded onto clean coverslips in culture medium and the seeding process was 
repeated every other day for multiple times. The waiting period was determined 
based on our observation that a confluent cell layer formed on coverslips in 
2days at the seeding density used. After 6-8 seedings, a dense cellular construct 
was established on the coverslip, then a hydrophilic membrane was put on top of 



























































































































































































































































































































harvested by peeling off the membrane against the coverslips with hand-held 
forceps (Fig. 4-3:B). Meningeal constructs that were recovered with a hydrophilic 
membrane were able to maintain the size without further shrinkage (Fig. 4-
3:B).On the other hand, when the membrane was not applied and the construct 
were mechanically removed from the coverslips by gently scratching the 
coverslip surface with forceps, meningeal constructs shrank isotropically (data 
not shown). 
 
4.3.3 Characterization of Engineered Meningeal Fibroblast Constructs 
 
Engineered meningeal constructs were incubated with 
immunohistochemical markers for ECM proteins detection. Similar to the ECM 
protein expression observed in harvested native adult rat meningeal tissue (Fig. 
4-1), engineered meningeal constructs also reacted positively with antisera 
against type-1 Coll, CSPG, FN and LN (Fig. 4-4:A, B, C and D). Cross-sectional 
images showed the multilayered structure of the engineered meningeal construct 
and the distribution of ECM proteins throughout the thickness of the construct 
(Fig. 4-5). The thickness of the engineered constructs increased with the number 
of cell seedings. There was a significant difference in the thickness between 6 
seeding and 8 seeding constructs (Fig. 4-2; ANOVA, post hoc p<0.05). There is 
also a significant difference in the thickness between adult rat dural mater and  6 
seeding and 8 seeding constructs, respectively (Fig. 4-2; ANOVA, post hoc 








Fig.4-4: Representative extracellular matrix protein profile of engineered 
meningeal fibroblast constructs. Engineered meningeal constructs had similar 
expression of major ECM proteins as the natural rat dural mater and were 
positively reacted with antisera against type-1 Coll (A, in green), CSPG (B, in 












Fig.4-5: Representative cross-sectional images of engineered meningeal 
fibroblast constructs. Indirect immunohistochemical reactions showed that the 
examined ECM proteins, FN (B, in red), Coll (C, in green), CSPG (D, in red), LN 
(E, in red), were distributed throughout the entire engineered constructs. (A) 
DAPI staining demonstrated the multilayered structure of the engineered 
constructs. Actin micofilament was used as the cytoskeletal marker for meningeal 
fibroblasts (F, in green). Scale bar= 50 μm. 
 
 
4.3.4 Decellularization and Characterization of Acellular  
 
Meningeal ECM Constructs 
 
Following harvesting from coverslips with membranes attached, the 
meningeal constructs were first immersed in hypotonic buffer containing EDTA 
and protease inhibitors to weaken integrin-ECM interactions and deactivate 
proteases that were released due to cell body rupture. Then the constructs were 
treated with 0.1% SDS to remove cellular components, followed by DNase and 
RNase treatment to break down DNA and RNA. The decellularized meningeal 
ECM constructs became more transparent following lyophilization when 





same size and configuration as the cellular constructs (Fig. 4-6:A and B). All 
major ECM proteins investigated, including type-1 Coll, CSPG, FN and LN, were 
preserved within the decellularized meningeal ECM constructs with no positive 
DAPI+ cell nuclei (Fig. 4-7:A, B, C and D). The presence of actin microfilament, 
an intracellular cytoskeleton protein, was also investigated to confirm the 
effectiveness of the decellularization processes. Little to no immunofluorescent 
signals for actin microfilaments and meningeal fibroblast nuclei were found 
following decellularization (Fig. 4-7:E) whereas abundant DAPI+ cell nuclei and 
strong actin filament expression were observed in the cellularized counterparts 



















Fig. 4-6: Representative macroscopic images of lyophilized meningeal fibroblast 
constructs and decellularized, meningeal ECM constructs. (A) A piece of opaque, 
sheet-like material was obtained following lyophilization of a meningeal cell 
construct. (B) A lyophilized, acellular meningeal ECM construct maintained a 
similar size and configuration as the cellularized counterpart; however, appeared 
to be more transparent. Both biomaterials are mechanically stable and can be 

















Fig. 4-7: Representative ECM protein profile of decellularized meningeal ECM 
constructs. Indirect immunohistochemical reactions demonstrated that following 
decellularization, the acellular ECM constructs were positively stained for type-1 
Coll (A, in green), FN (B, in red), CSPG (C, in red) and LN (D, in red), similar to 
the native adult rat dura mater. In particular, a network of type-1 Coll fibers was 
clearly seen in the acellular ECM constructs. (E) On the other hand, little to no 
immunofluorescent signals of actin microfilaments and DAPI+ cell nuclei were 
observed in the acellular ECM constructs following decellularization. (F) The 
cellularized meningeal fibroblast constructs were positively stained for 
intracellular cytoskeletal protein, actin microfilaments (in green) and DAPI+ cell 










4.3.5 Cell Culture on Decellularized Meningeal ECM Constructs 
 
Allogeneic primary rat meningeal fibroblasts were seeded onto 
decellularized meningeal ECM constructs to investigate whether the materials 
support cell adhesion and proliferation. Following 2days, meningeal fibroblasts 
were found to spread out on both ECM constructs and culture medium coated 
coverslip surfaces (for comparison) as visualized by actin microfilament staining 
(Fig. 4-8: A and B). In contrast to meningeal fibroblasts grown on culture medium 
coated coverslips, whose cell bodies flattened and spread out isotropically (Fig. 
4-8:A), meningeal fibroblasts cultured on acellular ECM constructs were found to 
be morphologically elongated, demonstrating that the ligand distribution of the 
underlying ECM matrices influences cellular morphology (Fig. 4-8:B).When 
meningeal fibroblasts and astrocytes were plated onto decellularized ECM 
constructs, no difference in the ability of acellular ECM constructs to support cell 
adhesion of both cell types was observed (Fig. 4-8:C). However, in a 4-day cell 
proliferation assay, a significantly higher proliferation rate of allogeneic 
meningeal fibroblasts over allogeneic astrocytes was found on the decellularized 
ECM constructs (Fig. 4-8:D; ANOVA, post hoc p<0.05). 
 
4.4. Discussion 
Dura mater is the outermost meninges tissue that isolates and protects the 
CNS tissue and it is the general surgical practice to repair dural defects with a 
biomaterial patch to restore its barrier functions [1, 3]. Various materials ranging 
from autografts [58, 89], allografts [49-52], xenografts [54-57], degradable and 



















Fig. 4-8: Acellular meningeal ECM constructs support primary meningeal 
fibroblast adhesion and proliferation. Representative images of the morphology 
of meningeal fibroblasts cultured on serum-coated coverslip surfaces (A) and 
acellular ECM constructs (B) following 2 days in culture. In contrast to meningeal 
fibroblasts which flattened and spread out isotropically on the coverslip surfaces, 
the meningeal fibroblasts appeared to be morphologically elongated on the ECM 










Fig.4-8 continued: (C) No significant difference in the ability of the acellular 
constructs to support allogeneic meningeal fibroblast or astrocyte adhesion was 
observed. (D) On the other hand, a significant higher proliferation rate of tissue 
specific meningeal fibroblasts over astrocytes were found on the ECM constructs 






been tested as dural substitutes. However, poor biocompatibility and 
complications associated with many of these materials, including chronic 
inflammatory responses and immunogenic reactions, have restricted their wide 
spread use [35-44, 71-74]. While collagen-based dural repair products are 
currently widely used by neurosurgeons, the fact that they are derived from 
tissue sources other than the meningeal dura tissue suggests these biomaterials 
might not carry appropriate biological cues, which have been suggested to 
promote tissue type specific regeneration [81-84]. This idea of using tissue type 
specific ECM materials for targeted tissue repair is supported by a study where 
foreign tissue formation was observed when ECM scaffolds derived from 
mismatched tissue types were introduced for myocardial repair [85]. 
To provide an improved alternative to clinicians, we have developed novel 
biomaterial constructs that are derived by the meningeal fibroblasts, the major 
supporting cell type reside with the natural meninges tissue, including the dura 
mater. Both cellularized and acellular ECM constructs derived by meningeal 
fibroblasts are mechanically stable and can be handled with hand-hold forceps. 
Indirect immunohistochemical analysis demonstrated that both types of 
engineered constructs expressed similar ECM proteins as adult rat cortical dura 
mater, suggesting the complexity of the ECM matrix was recapitulated in a 
manner that mimics the natural extracellular milieu in vivo. In addition, acellular 
ECM constructs support allogeneic meningeal fibroblast adhesion and promote 





approach may be useful to produce biomaterials that may be used to repair the 
damaged meningeal tissues of the CNS. 
Different approaches have been developed to create 3D cellular 
constructs in vitro, utilizing either temperature-responsive surfaces to facilitate 
continuous cell sheet detachment [94, 95, 106] or nanometer-sized ECM films to 
facilitate the formation of multilayered structure [96, 97]. In addition to preclinical 
animal studies, such multilayered cellular constructs have also been successfully 
applied in a clinical study on human subjects [94]. In our case, the formation of 
multilayered meningeal fibroblast constructs was achieved simply by repeating 
seeding cells in the serum-supplemented culture medium. Our observation was 
not cell type specific since we have observed the formation of similar 
multilayered structure with at least 3 different cell types (i.e., meningeal fibroblast, 
astrocyte and human vocal fold fibroblast) using our approach. Moreover, our 
simple approach to engineer multilayered cellular constructs is advantageous in 
a way that avoids the expensive cost of using high concentration ECM protein 
solutions [96, 97], purchasing special culture substrates or the complex chemistry 
processes involved in fabricating one [94, 95, 106].   
While the allogeneic cellular tissue constructs have been shown to hold 
therapeutic potential for repairing a variety of damaged tissues in animal models 
[95, 106], autologous cell sources remain the optimal choice when it comes to 
patients due to the immunogenic rejections following transplantation [94]. 
However, it may be time consuming to expand autologous cells in culture in order 





meningeal ECM constructs were also developed following decellularization to the 
cellularized constructs in order to provide an alternative for autologous cell 
therapy. The decellularized ECM constructs preserved only cell-produced ECM 
materials, which are generally considered to be immunologically tolerable 
between species and would elicit minimal inflammatory response [98]. In addition, 
the acellular ECM biomaterials can be easily sterilized, stored and used as over-
the-counter products. Indirect immunohistochemical reactions demonstrated that 
both cellular and nuclear materials were effectively removed as evidenced by the 
absence of DAPI+ nuclei and immunofluorescent signals of intracellular actin 
micofilaments. On the other hand, a similar ECM protein profile to the native rat 
meningeal dura tissue was preserved, suggesting appropriate biological function 
of the ECM was maintained. The decellularized meningeal ECM constructs also 
have a similar ligand organization as the decellularized rat dura mater, 
particularly a network of intermingled collagen fibers (data not shown). 
ECM is also known as the natural carrier of cell-secreted growth factors 
[99, 100]. Although the content of growth factors within the acellular meningeal 
ECM constructs in the current study was not investigated, the potential 
candidates that might be preserved in the matrices include NGF, NT-3 and bFGF 
[101]. These trophic factors could be released upon ECM construct degradation, 
which would further modulate cell functions and mediate subsequent tissue 
remodeling processes [102, 103]. The bioactivity of these growth factors has 
been shown to remain active even following decellularization or sterilization [105, 





able to affect infiltrating macrophage phenotype and tissue remodeling outcome 
[86]. In particular, acellular ECM scaffolds have been shown to result in primarily 
antiinflammatory M2 macrophage phenotype at the implantation site, which then 
lead to constructive tissue remodeling. 
Rat meningeal fibroblasts were seeded atop decellularized meningeal 
ECM constructs to investigate the ability of ECM constructs to support cell 
adhesion and proliferation in vitro. Although we did not find statistically more 
allogeneic meningeal fibroblasts than allogeneic astrocytes adhered on the ECM 
constructs, a significantly higher proliferation rate of meningeal fibroblasts over 
astrocytes was observed, suggesting the acellular ECM constructs can facilitate 
dural defect regeneration by promoting host dural meningeal fibroblast 
proliferation. In addition, it has also been shown that tissue specific ECM attracts 
migration of tissue-matched cell types [84]. However, in addition to the tissue 
specificity which has been shown previously to play a role in influencing cell 
proliferation [82, 83], we cannot rule out the possibility that the significant 
difference seen in the cell proliferation assay was also contributed by the fact  
that meningeal fibroblasts inherently proliferate faster than astrocytes in vitro. 
The meningeal fibroblast constructs and acellular meningeal ECM 
constructs developed in this study are of sheet-like structure and can be handled 
with hand-held forceps, demonstrating that both biomaterial constructs can be 
easily applied as patching materials for injured meningeal dura tissue repair. 
While meningeal cellular constructs can be directly applied as biological 





acellular meningeal ECM constructs can be prepared as an alternative to 




Meningeal fibroblast derived biomaterial constructs were developed in the 
present study. The fact that both cellularized constructs and decellularized ECM 
constructs were derived by the specific cell type that composes the natural dural 
tissue suggests these biomaterials might carry appropriate biological cues that 
could stimulate tissue specific regenerative response. As studies have shown the 
advantage of introducing tissue type specific ECM for damaged tissue targeted 
for repair, meningeal fibroblast derived constructs might hold superior therapeutic 
potential for neurosurgical applications. The ongoing research is investigating the 
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SUMMARY, CONCLUSIONS, AND FUTURE WORK 
 
 
5.1 Summary and Conclusions 
 
SCI is extremely debilitating to patients and costly to the health care 
system. With significant SCI attributed mortality and morbidity in the world, 
various therapeutic strategies, have been investigated, either experimentally and 
clinically, to improve patients’ quality of life. Studies utilizing pharmacological 
methods to mitigate the inhibitory components of the glial scar and facilitate 
axonal regeneration following SCI have been the primary approaches in the field. 
In this research, we aimed to tackle the issue from a novel perspective by 
developing cell-derived tissue engineered biomaterials that can be used in 
combination with other therapeutic approaches to improve the efficacy of current 
treatments.  
In Chapter 2, a 2D model of oriented astrocyte monolayers was developed 
in vitro and served as the framework of the engineering approach that was 
utilized in Chapter 3 to develop implantable, oriented astrocyte based biomaterial 
constructs. The oriented astrocyte monolayer model clearly demonstrates that it 
is a purely biological mechanism by which oriented astrocytes guide DRG neurite 
outgrowth as planar culture substrates were provided. In particular, by culturing 





spatial distribution of astrocyte associated insoluble ligands play the principal role 
in guiding neurite trajectories. Antisera experiments further showed that astrocyte 
associated FN functions as a potent neurite outgrowth guiding ligand. Last, we 
demonstrated that nanometer level surface guidance cues can be transmitted 
through multiple cell layers to organize multilayered cellular constructs on the 
scale of tens of microns thick. 
In Chapter 3, 3D astrocyte constructs with either randomly organized or 
oriented cellular organization were developed in the absence of synthetic 
scaffolding materials. The recovered astrocyte constructs are mechanically 
stable and implantable. The confocal microscopy showed that the anisotropic 
spatial distribution of various astrocyte associated ligands is maintained in the 
oriented astrocyte constructs whereas no biased orientation distribution of the 
same ligand profile is observed in randomly organized constructs. Oriented 
astrocyte constructs maintain the ability to direct regenerating DRG neurite 
outgrowth in a direction parallel to the spatial distribution of associated ligands in 
vitro, similar to the 2D monolayer model. In addition, recovered astrocyte 
constructs are manipulatable, which can be engineered into multistacked 
constructs or self-holding tubular structures. Moreover, the cellular components 
of the cellularized constructs can be removed to harvest acellular ECM 
constructs that would elicit the minimal immune response and result in 
constructive tissue remodeling following implantation. Acellular, oriented 
astrocytes derived ECM constructs are also able to guide neurite outgrowth and 





In Chapter 4, meningeal fibroblast-derived biomaterials were developed 
using the same engineering approach described in Chapter 3 for dural defect 
repair. Dural defect reconstruction has been shown to be able to prevent 
meningeal fibroblast infiltration and collagenous material deposition into SCI 
lesion center, which benefits the regeneration process of the cord. Indirect 
immunohistochemical reactions showed that both engineered meningeal 
constructs and acellular meningeal ECM constructs have similar ECM protein 
profile as the native adult rat dural mater, suggesting appropriate biological 
function of the ECM is maintained. The spatial distribution of the ligands within 
the acellular ECM constructs was found to influence the morphology of overlying 
proliferating allogeneic meningeal fibroblasts. Although no difference in the ability 
of meningeal ECM constructs to support either astrocytes or meningeal fibroblast 
adhesion was observed, we did find a significantly higher proliferation rate of 
meningeal fibroblasts over astrocytes on the meningeal ECM constructs.  
 
5.2 Future Work 
 
5.2.1 The Effect of Cellular Organization on Overcoming Inhibitory  
 
Astrocyte-Meningeal Fibroblast Interface 
 
As outlined in this dissertation, infiltration of meningeal fibroblasts and 
resulting deposition of collagenous materials are common tissue response 
scenarios observed following penetration or laceration SCI, leading to the 
formation of a fibrotic scar [1, 2]. The repulsive effect of meningeal fibroblast 
infiltration on axonal regeneration has been demonstrated both in vitro and in 







astrocyte patches and readily cross from the meningeal cell territories to 
astrocyte territories, but failed to extend in the other direction. It has been shown 
that pharmacological or neurotrophin treatments can moderately increase the 
crossing behavior in vitro[4, 5]. 
In Chapter 2, we demonstrated that astrocyte alignment can be 
engineered using nanochemically printed protein pattern, which led to the 
development of a network of organized, anisotropically distributed astrocyte 
associated ligands. It has been proposed that the efficacy of growth cone 
pathfinding would be more efficient in the organized extracellular milieu as the 
complex decision making process encountered when exploring the disorganized 
extracellular territory, involving growth cone adhesion and retraction, is avoided. 
Therefore, it would be interesting to test in vitro if the inhibitory 
astrocyte/meningeal cell boundary could be overcome by simply manipulating the 
cellular organization of both cell types at the interface using the anisotropic 
protein pattern. 
 
5.2.2 Cell-Derived ECM Constructs and Macrophage Polarization 
 
The fact that studies utilizing either transplantation of activated 
macrophages or depletion of hematogenous macrophages have been shown to 
promote functional recovery following SCI leads to considerable debate as to 
whether these inflammatory cells play an adverse or beneficial role on tissue 
repair and axonal regeneration [6, 7].This controversy has been elucidated by 
recent studies that shed light on the heterogeneity of activated 





9].In particular, M1 inflammatory macrophages have been demonstrated to 
mediate neurotoxic effects on regenerating axons whereas M2 antiinflammatory 
macrophages promote axonal regeneration, even on inhibitory substrates in vitro. 
In vivo, M1 inflammatory macrophages have been shown to predominate the 
lesion site starting 14 days following SCI [8]. 
It has been shown in non-neuronal tissues that implantation of acellular 
ECM scaffolds lead to a predominantly M2 antiinflammatory macrophage 
phenotype and constructive tissue remodeling at the implantation site whereas a 
primarily M1 inflammatory phenotype is observed when cellular grafts are 
implanted [10]. Therefore, it will be interesting to test if astrocyte derived ECM 
constructs would shift the polarization of macrophages/microglia at the SCI lesion 
site toward a predominantly M2 antiinflammatory phenotype, which leads to 
facilitated axonal regeneration, whereas cellularized astrocyte constructs would 
induce a primarily M1inflammatory macrophage phenotype, which inhibits 
regeneration. In addition, implantation of oriented astrocyte derived biomaterial 
constructs also provides an opportunity to investigate the ability of these 
biomaterial constructs to organize the orientation of glial scar-forming reactive 
astrocytes surrounding the lesion site and the effect of cellular organization on 
axonal regeneration.  
This study could provide information regarding whether having an 
inflammatory macrophage phenotype at the lesion site or the presence of an 
unorganized pathway is the predominant mediator of failed axonal regeneration 





these questions, future studies could be conducted with four experimental groups 
including implantation of oriented astrocyte-derived biomaterial constructs 
(cellularized and acellular) as well as randomly organized astrocyte-derived 
constructs (cellularized and acellular) in a hemisection SCI model as it is 
relatively easy to generate and reproducible [19].  
Although studies have shown that ECM scaffolds result in a predominantly 
M2 antiinflammatory macrophage phenotype at implantation site, it is still 
unknown what drives the differentiation of macrophages. As macrophages have 
been demonstrated to be the primarily mediators of ECM degradation and 
modification [11], it is possible that macrophage polarization is at least partially 
mediated by ligands they digest from the matrix and then take up in the cell 
bodies. The simple approach developed in the thesis work for harvesting cell-
derived ECM constructs could potentially be applied to genetically modified cell 
types that are engineered to upregulate or ablate the secretion of particular types 
of ECM proteins. Use of genetically modified cell types provides the opportunity 
to study the effects of ECM components on inducing macrophage polarization. 
On the other hand, by crosslinking ECM constructs, which has been shown 
previously to reduce the extent of ECM degradation [12], we could also 
investigate if degradation of ECM materials plays a role on macrophage 
polarization. These studies could provide information on engineering ECM 
materials to induce a primarily antiinflammatory tissue response at the injury site. 
In the current study, ECM constructs with or without organized protein 





study whether specific macrophage phenotypes would be simply induced by the 
ligand organization present in ECM constructs in vitro. Moreover, if distinct 
macrophage polarizations were observed on the two different ECM substrates 
engineered, it would be interesting to investigate how long the polarized state of 
macrophages could be maintained and if the presentation of organized ligands 
could overwhelm the effects of different cytokines shown to polarize 
macrophages to specific phenotypes when added to culture media [13]. This in 
vitro study would provide insights on designing novel biomaterial coatings to 
improve biocompatibility via engineering ligand presentation. 
The spatial distribution of each protein ligand within the ECM constructs 
engineered (i.e., disorganized and organized) and their relative distributions 
could be revealed by indirect immunohistochemical reactions against specific 
protein ligands. The revealed protein distributions could then be converted into 
digitalized image files and fabricated into different patterns onto PDMS printing 
devices. The protein patterns could then be printed onto biomaterial surfaces 
using multiprotein microcontact printing approach such that the relative 
distribution of multiple protein ligands is preserved [20]. Macrophages could then 
be seeded on printed protein patterns and the ability of ligand organization on 
inducing macrophage polarization could be evaluated using cell surface markers 
or secreted cytokine profiles. 
In addition to ligand organization, by comparing the M2/M1 macrophage 
ratio seen on distinct protein ligand combinations that are printed onto 





which ligand(s)’s organization plays the most important role on macrophage 
polarization. 
 
5.2.3 Injectable Cell Type-Specific ECM Biomaterials 
 
Several rodent SCI models, including complete transection, hemisection 
and compression/contusion injures, have been developed to study the cellular 
and molecular response following SCI and test the efficacy of various 
experimental therapeutic strategies [14-16]. While the transection and 
hemisection SCI models are relatively easy to generate and reproducible, they 
are not clinically relevant to the human SCI, where the majority of human SCI is 
contusion/compression injury [17]. The hallmark of this type of injury is the 
formation of an oval-shaped cystic cavity in the center of the lesion site with a rim 
of preserved spinal cord tissue [14]. To prevent causing more damage to the 
remaining tissue and nerve fibers, therapeutic strategies utilizing minimally 
invasive techniques such as injectable biomaterials are preferred to fill the cavity. 
In this dissertation, a simple approach to prepare cell type-specific ECM 
matrices was developed. It is interesting to investigate the feasibility to develop 
an injectable biomaterial from these cell type specific-ECM materials for delivery 
to sites of interest by minimally invasive techniques and potentially conform to 
any three-dimensional wounded defects. It has been shown that injectable ECM 
gels can be prepared from digesting porcine bladder [18]. Moreover, multiple cell 
types can be applied at the same time during construct fabrication to increase the 
complexity of the derived ECM scaffolds. This would better mimic the natural in 





ECM gels to serve as carriers for delivery of live cell suspensions or matrices for 
controlled release of growth factors and cytokines that would promote cell 
survival, angiogenesis and guide tissue repair. This study provides information 
on developing tissue type specific ECM materials, which can be introduced to 
injury sites through minimally invasive techniques. 
 An in vitro experiment could be first conducted to evaluate the effect of the 
complexity of ECM gels on various cellular functions, such as cell survivability, 
proliferation and phenotype expression. ECM constructs (e.g., derived from a 
single cell type or multiple cell types) could be engineered and decellularized 
according to methods described in this thesis work, then prepared into gel form 
as described previously [18].ECM gel derived from natural tissue that contains 
the same cell types used for engineering ECM constructs could be used for 
comparison. Cell suspensions could be mixed with different ECM gels and 
cultured in vitro. Cell live/dead assay, proliferation measurement kit and in situ 
hybridization technique could be used to reveal cellular functions within different 
ECM gels. For in vivo test, a rat myocardial infarction model could be used to test 
the ability of cell-derived ECM gels (e.g., single cell type or multiple cell types) to 
promote tissue regeneration [21] and naturally derived myocardial matrix gel 
could be used for comparison [22].  
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